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Research Experience for Undergraduates
University of Arkansas
The University of Arkansas Department of Chemistry and Biochemistry hosted a
National Science Foundation sponsored Research Experience for Undergraduates (REU) summer
program for the 23rd year. The department first hosted an REU in 1959. The 10-week summer
program, funded by the National Science Foundation, allowed students an opportunity to gain
hands-on experience in a chosen research area while introducing them to careers in scientific
research in areas including analytical chemistry and sensor technology, biochemistry and protein
dynamics, inorganic chemistry and nanotechnology, organic chemistry, and physical and
theoretical chemistry.
Undergraduate chemistry majors, who were sophomores or juniors in fall 2010, applied
to the program, which took place at the University of Arkansas, Fayetteville.
Outside the lab, students met each week to hear presentations from campus experts about
topics ranging from how to get into graduate school and test-taking skills to ethics, and how to
make a poster presentation. A number of social activities took place throughout the summer to
give students a chance to interact.
Selected students received a scholarship to pay for room and board and an allowance to
attend a regional or national chemical conference in the 2011-2012 academic year. Students
involved in the program were enrolled as students at the U of A and received one hour of
research credit. The program was conducted from May 22, 2011 to July 28, 2011.
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Tony Jude Award
Mississippi native Edward Evans, Jr. was the recipient of the Tony Jude Award for his summer
research. He is a student at Wabash College in Indiana. The Tony Judy Award was created in
2002 to recognize a student for outstanding research. It is awarded in memory of a former REU
student who returned to the University of Arkansas and obtained a doctorate degree.
Ed, under the direction of Professor Paul Adams, presented a poster entitled “Expression
and Purification of Cdc42 and PBD46, an Important Ras-Protein Complex.”
He is pictured below with Program Co-Director Professor David Paul.
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2011 REU Participants
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Faculty Project List
Paul Adams
Assistant Professor

Biophysical Characterization of Proteins Associated with Signal
Transduction

Neil Allison
Associate Professor and ViceChair

Synthesis and Chemistry of Potential Organometallic Anticancer
Drugs

Jingyi Chen
Assistant Professor

Chemical synthesis of Platinum-based nanostructures as
electrocatalysts for fuel cell application
or
Synthesis and surface modification of cage-like nanoparticles for
drug delivery

Dan Davis
Professor

Protein-Protein Interactions in Photosynthesis: Structure-Function
Relationships in Electron Transfer Proteins

Ingrid Fritsch
Professor

Microelectrochemical detection and microfluidics for lab-on-a-chip
applications: protein, DNA, and microorganism analysis

Denise Greathouse
Research Assistant Professor

Characterization of structure and peptide-lipid interactions of
membrane active antimicrobial peptides

Bob Gawley
Distinguished Professor

Synthetic and mechanistic organ(ometall)ic chemistry

Colin Heyes
Assistant Professor

Development of Nanocrystals for Biophysical Applications

Roger Koeppe
University Professor

Biophysical Studies of Single-Span Transmembrane Proteins and
Membrane Channel Gating

T.K.S. Kumar
Associate Professor

Structure, dynamics, folding and interactions of proteins

Matt McIntosh
Professor

Total Synthesis of Biomedically Significant Complex Natural
Products

Frank Millett
Distinguished Professor

Biological Electron Transfer

David Paul
Associate Professor

Development of Chemical Sensors for Clinical and Environmental
Applications

Peter Pulay
Distinguished Professor

Ab initio Calculation of the Vibrational and NMR Spectra of
Protein Models

Joshua Sakon
Associate Professor

Structure and function of drug-targets
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Derek Sears
University Professor

For an expanded REU program in Space Science visit:
http://spacecenter.uark.edu/97.htm

Julie Stenken
Professor

Measurement of Chemical Communication (Signaling) molecules,
e.g., cytokines, neuropeptides, etc, Biosensors
or
In Vivo Chemical Analysis

Wes Stites
Professor

Exploring the influence of the denatured state upon protein stability,
or
Isolation, characterization, and impact upon blood clotting of
human thrombomodulin in disease.

Z. Ryan Tian
Associate Professor

Syntheses and applications of ordered and complex nanostructures

Charles Wilkins
Distinguished Professor

Matrix-assisted Laser Desorption Fourier Transform Mass
Spectrometry for Whole-Cell Bacteria and Polymer Analysis

Nan Zheng
Assistant Professor

Natural product synthesis, method development, and
organometallics
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UNIVERSITY OF ARKANSAS
NSF – CHEMISTRY – REU ‐ SUMMER 2011

NIH – CHEMISTRY/ENGINEERING ‐ INBRE
Activities and Events
Sunday, May 22
1:00 p.m. – 4:00 p.m.

Arrival, Check‐In & Registration

Maple Hill East (front desk: (479)718‐2590)

4:30 p.m. – 5:30 p.m.

Housing Orientation
Maple Hill South Classroom, Room 143

6:00 p.m. – 7:30 p.m.

Welcome Dinner
University House, Whole Hog Barbeque

Monday, May 23
7:00 a.m. – 8:00 a.m.

Breakfast
Quad Dining Room

8:15 a.m.

Meet in quad lobby to go to university together

8:30 a.m. – 9:45 a.m.

Group Photo
Front of Library

9:45 a.m. – 11:45 a.m.

Campus Logistics (Concurrent Sessions)

RED
YELLOW

Session I: 9:45‐10:30 a.m. Session II: 10:45‐11:30 a.m. (Carver, MEEG, SPAC, Food Sci)
Session II: 9:45‐10:30 a.m. Session I: 10:45‐11:30 a.m. (CHEM, Phys, MicroEP, CeMB)

Session I:

Session II:
12:00 p.m. ‐ 1:00 p.m.

ID Cards Issued, UARK email account setup
Arkansas Union
Parking and Transit available: $22.65 per parking
tag. License plate number and your vehicle registration
are required for purchasing a tag. May park in lot 40
Sunday for unloading. Must move car to lot 41 (near
Reid Hall) or 37 (corner of Garland and Cleveland)
before Monday morning. Tag needs to be displayed by
Tuesday to avoid ticketing.
Library Orientation
University of Arkansas Mullins Library, Room 102

Opening Luncheon
Place: Student Union Ballroom
Speaker: Dr. Donald Pederson, Vice Chancellor, Professor of
Physics
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1:00 p.m. – 2:30 p.m.
2:30 p.m. – 4:30 p.m.

Tuesday, May 24
8:00 a.m. – 10:00 a.m.

Campus Tour
Meet in Ballroom with campus ambassadors
Departmental Logistics
Place: Chemistry Building Room 105
Meet your Mentor: Refreshments will be served
Get Keys, Take Photos
Safety Briefing: Bill Durham, Department Chair
CHEM 105

11:00 a.m. – 12:00 p.m.

CHEMISTRY Library Tour
Place: MULLINS 102, moving to CHEM Library
Librarian: Luti Salisbury

12:00 noon

Go to Your Lab and Get Started!

Wednesday, May 25
8:00 a.m.

Report to your lab

5:30 p.m. – 7:00 p.m.

Dinner & Dialogue
Place: Donald W. Reynolds Center, Seminar Room A
Speaker: Dr. Rosemary Ruff
Topic: Research and Ethics

Friday, May 27
1:00 p.m.

REU/INBRE Group Meeting
CHEM 105
Speaker: Julie Stenken
Topic: From REU student to Endowed Chair: Lessons in
Seeking and Taking all Opportunities

Saturday, May 28– Monday May 30 Free for Memorial Day Weekend
Wednesday, June 1
5:30 p.m. – 7:00 p.m.

Dinner & Dialogue
Place: Arkansas Union Ballroom
Speaker: Marcelo Schubach
Topic: Science Careers

Thursday, June 2
6:00 p.m. – 9:00 p.m.

Evening Entertainment
Host: Chemistry
Location: Devil’s Den State Park (bring swim suit!)

Friday, June 3
1:00 p.m.

REU/INBRE Group Meeting
CHEM 105
Speaker: Jingyi Chen
7

Title: Engineering multifunctional nanomaterials for
biomedical applications
Wednesday, June 8
5:30 p.m. – 7:00 p.m.

Dinner & Dialogue
Location: Alumni House
Speaker: Brady and Grady Wright
Topic: Branding Yourself

Thursday, June 9
6:00 p.m. – 9:00 p.m.

Evening Entertainment
Host: MicroEP and SPAC
Location: The Gardens

Friday, June 10
1:00 p.m.

REU/INBRE Group Meeting
CHEM 105
Speaker: Jack Lay
Title: Rapid Characterization of Lipids by MALDI MS

Wednesday, June 15
5:30 p.m. – 7:00 p.m.

Dinner & Dialogue
Place: Donald W. Reynolds Center, Seminar Room A
Speaker: Graduate Student Panel
Topic: Q & A Session

Thursday, June 16
6:00 p.m. – 9:00 p.m.

Evening Entertainment
Host: Carver
Location: Lokomotion

Friday, June 17
1:00 p.m.

REU/INBRE Group Meeting
CHEM 105
Speaker: Dr. Colin Heyes
Title:

Monday, June 20

Canoe Trip

Wednesday, June 22
5:30 p.m. – 7:00 p.m.

Dinner & Dialogue
Place: Donald W. Reynolds Center, Seminar Room A
Speaker: Dr. Lynn Meade
Topic: How to Give an Effective Presentation

Thursday, June 23
6:00 p.m. – 9:00 p.m.

Evening Entertainment
Host: CeMB
Location: Razorback Malco Theater

Friday, June 24
1:00 p.m.

REU/INBRE Group Meeting
CHEM 105
Speaker: T.K.S. Kumar
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Topic: Molecular interactions that are crucial for cell growth
and differentiation
Saturday, June 25
10 a.m.

Practice GRE and GMAT test offered
Location: MEEG Auditorium ‐ Testing is FREE
Participation requires pre‐registration

Mon‐Tues, June 27‐28

NCTR Tour
Jefferson, AR
Overnight stay in Little Rock, Dinner w/ INBRE students

Wednesday, June 29
5:30 p.m. – 7:00 p.m.

Dinner & Dialogue
Place: Donald W. Reynolds Center, Seminar Room A
Speaker: Alfred Dowe & Vicky Hartwell
Topic: Applying to Graduate School & Funding your Graduate

Degree
Thursday, June 30

Evening Entertainment
Host: Mechanical Engn.
Location: Ozark Lanes

Friday, July 1
1:00 p.m.

REU/INBRE Group Meeting
CHEM 105
Half‐way Progress Report Presentation
Progress Reports Due

Saturday, July 2 – Monday, July 4 Free for Independence Day Weekend
You must return to Fayetteville by 8:00 a.m., July 5
Friday, July 8
10:30 a.m.

INBRE student presentations
Access Grid – Mullins Library

1:00 p.m.

REU/INBRE Group Meeting
CHEM 105
Speaker: Bob Gawley
Topic: Why did Alice say to Kitty: “Perhaps looking glass milk
isn’t good to drink?” A guided tour from Lineland to Spaceland.

Wednesday, July 13
3:00p.m. – 7:00 p.m.

Final Carver Presentations
Willard J. Walker Hall ‐ All are invited

Friday, July 15
11:00 a.m.

INBRE student presentations
Access Grid – Mullins Library

1:00 p.m.

REU/INBRE Group Meeting
CHEM 105
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Speaker: Ingrid Fritsch
Topic: From Research to Commercialization
Friday, July 22
10:30 a.m.
Library

INBRE student presentations
Fayetteville Students presenting ‐ Access Grid – Mullins

1:00 p.m.
Thursday, July 28
10:00 a.m.

REU/INBRE Group Meeting
Chem 105
David Paul ‐ How to Make a Poster
Meeting in Miniature, Lunch Served
CHEM 105

Friday, July 29
5:00 p.m.

End of Program
Final reports due / Dorm check‐out

Saturday, July 30
By 11:00 a.m.

End of Program
Get out of the Dorm, last check‐out
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Phospholipid Analyses Utilizing GC-MS
Terry Anderson, Philander Smith College
Little Rock, Arkansas

Abstract
Phospholipids such as Phosphatidylcholine, are some of the most abundant lipids
found in nature. These lipids are able to be analyzed by using the GC-MS, although the
method for analysis is not as efficient. In this study a more efficient process of analysis for
phospholipids was developed with possible application to tissue analysis. Utilizing an
esterfication process to transform the lipids from a non-volatile state to a volatile state for
GC-MS analysis. The phospholipids Phosphatidylcholine & Phosphatidylinositol were
found to form FAMES better with a basic catalyst such as NaOCH3. Whereas a
phospholipd such as Sphingomyelin was able to use an acidic catalyst such as BF3 to create
FAMES. When standard samples were run with multiple test a Relative Standard
Deviation (RSD) of below 1%. When a beef tissue sample underwent lipid extraction the
sample was used in the developed protocols. The tissue lipids were identified and resulted
in an RSD parallel to the standard lipids used in the experiment.

Introduction
A GC-MS is two part Instrument, A) a Gas Chromatograph (GC) for separating volatile
compounds; and B) a Mass Spectrometer (MS) for analyzing the mass-to-charge ratio of the
substances exiting the GC.
The purpose of this research was the development of proper analytical methods and their
applications to tissue samples to properly profile the phospholipids. The only way to profile
lipids in a GC-MS is an esterfication process which is necessary to make the lipid more volatile,
or as a Fatty Acid Methyl Ester (FAMES) to move through the GC-MS column. A tissue
extraction process has to be performed to obtain the lipids. Then esterfication process must be
done on the extract.
The lipids that were used in this project: Phosphatidylcholine(PC),
Phosphatidylnostiol(PI), are of the glycreophospholipids lipid classification, and
Sphingomyelin(SM) of the sphingolipids lipid classification, are some of the most abundant
lipids that are found in nature.
Phosphatidylcholine (PC):
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Sphingomyelin (SM):

Experimental Procedures
GC-MS Lipid Standard Fatty Acid Methyl Ester's (FAMES) Preparation:
Weigh 2mg of standard lipid sample into a 16 X 125 mm Pyrex screw cap culture tube.
Next, add 2 ml of BCl3-methanol 12% (w/w)*. Then heat the test tube in a hot water bath for 510† min, at 60 C. Afterwards remove the test tube from heat and allow to cool for 10 min, before
adding 1 ml of Distilled water and 1 ml of Hexane. Agitate the mixture, then allow the layers to
partition apart. Remove the top organic layer and dry the layer in a separate vial of anhydrous
sodium sulfate. Allow layers to form again, remove the top layer, noting only to remove the top
liquid layer, no solid particles. Place this layer into a GC vial for storage at -20°C.
GC-MS Lipid Standard Mixture Fatty Acid Methyl Ester's (FAMES) Preparation:
Weigh .25mg of PC & SM sample, and 25 ul of PI in to a 16 X 125 mm Pyrex screw cap
culture tube. Next add, 2 ml of BCl3-methanol 12% (w/w)*. Then heat the test tube in a hot
water bath for 1.5hrs, at 60 C. Afterwards remove the test tube from heat and allow to cool for 10
min, before adding 1 ml of Distilled water and 1 ml of Hexane. Agitate the mixture, then allow
the layers to partition apart. Remove the top organic layer and dry the layer in a separate vial of
anhydrous sodium sulfate. Allow layers to form again, remove the top layer, noting only to
remove the top liquid layer, no solid particles. Place this layer into a GC vial for storage at -20 C.
GC-MS Tissue Lipid Extraction & FAMES Preparation:
Take freeze-dried tissue sample and grind it in a blender for 10-15s at room temperature.
Next .5g of the tissue sample is placed into a 16 X 125 mm Pyrex screw cap culture tube. Next,
680 ul of Chloroform and 340 ul MeOH (in a 2:1 vol/vol) are added to the sample. Following
this, 2 ml of BCl3-methanol 12% (w/w)*. Then heat the test tube in a hot water bath for 1.5 hrs,
at 60 C with vigorous handshaking for every 5's, every 20 min. Afterwards remove the test tube
from heat and allow to cool for 10 min, before adding 2 ml of saturated NaHCO3 and 3 ml of
12

Hexane. Vortex the mixture, then centrifuge the mixture for 30 sec. Remove the hexane layer
and dry the layer in a separate vial of anhydrous sodium sulfate and Potassium Carbonate (10:1
wt/wt). Allow layers to form again, remove the top layer, noting only to remove the top liquid
layer, no solid particles. Place this layer into a GC vial for storage at -20°C.
GC-MS Temperature Gradient Method
Utilizing a Varian 320 Triple Quadrupole GC-MS the machine was set at an initial
temperature of 140°C, with a 5 min. hold. The temperature was then set at an increasing rate of
4°C/min to 240°C with a 15 min hold.

Results & Discussions
FAMES Catalyst Comparison:
When the catalyst BF3 was used in FAME procedure unique results followed regarding
the type of lipid that was used in the process. Gylcerophospolipids such as Phosphatidylcholine
(PC) (Fig. 2-1) when used with the BF3 procedure produced minimal FAMES with a decrease in
signal to noise ratio, and a reduced ion count. When utilizing NaOCH3 in the FAME procedure
the exact opposite occurs with a minimal amount of noise present in the GC-MS run. Ion counts
for the sample also increase dramatically when the base catalyst is used. The finding also applies
to Phosphatidylinositol (PI) lipid (Fig. 2-2) .
PC/BF3

PC/NaOCH3

Figure 2-1. Phosphatidylcholine(PC) catalyst comparison for FAMES preparation
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PI/BF3

PI/NaOCH3

Figure 2-2. Phosphatidylinositol(PC) catalyst comparison for FAMES preparation.

Although this is not the case for the sphingolipids lipid type, such as Sphingomyelin (SM) (Fig.
2-3) which has a better FAME creation with BF3 than with NaOCH3. Because of this all lipids
were used with their respective catalyst to obtain the best results.
SM/BF3

SM/NaOCH3

Figure 2-3. Sphingomyelin(SM) catalyst comparison for FAMES preparation.
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Lipid Standard FAMES Identification:
The FAMES of the standard lipid were identified based off of the possible methyl ester
that created from the fatty acids of the lipid. For PC & PI two major FAMES were identified
(Table 1-1,2) in correspondence to the structure provided. Multiple test runs under the same
conditions were run with all lipid standards. This resulted in a relative standard deviation (RSD)
at the retention time of each respective lipid to be below 1%. The standard lipid SM, on the
other hand only had one major FAME that was identified (Table 1-3). This lipid was also run
under the same conditions multiple times, and also resulted in an RSD of below 1%.

PC FAMES Identification Table
Average
Systematic Name
Retention
Time (min)

Formula

m/z

Shorthand RSD of
Designation Retention
Time

19.426 ±
0.0067

Hexadecanoic Acid, 15methyl, methyl ester

C17H36O2

272.2715 16:1

0.03%

23.553 ±
0.0085

15-Octadecanoic Acid, methyl C19H36O2
ester

296.2715 18:1

0.04%

Table 1-1. Phosphatidylcholine(PC) FAME ID Table.

PI FAMES Identification Table
Average
Systematic Name
Retention
Time (min)

Formula

m/z

Shorthand RSD of
Designation Retention
Time

23.398 ±
0.0070

11,14-Eicosadienoic Acid,
methyl ester

C21H38O2

322.5315 20:2

0.03%

24.147 ±
0.0067

Octadecanoic Acid, methyl
ester

C19H38O2

298.2872 18:0

0.03%

Table 1-2. Phosphatidylinositol(PI) FAME ID Table.

SM FAMES Identification Table
Average
Systematic Name
Retention
Time (min)
19.4247±
0.0071

Hexadecanoic Acid, methyl
ester

Formula

C17H34O2

m/z

Shorthand
Designation

270.2559 16:0

RSD of
Retention
Time
0.04%

Table 1-3. Sphingomyelin(SM) FAME ID Table.
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Lipid Standard Mixture FAMES Identification:
When the lipid standards were used in a combination that underwent the FAMES creation
process, as previously done singularly each FAME was identified based off of the carbon length
and retention time placement (Table 2-1, 2). Only two FAMES per catalyst were identifiable:
SM & PC with the BF3 catalyst; and PC & PI with the NaOCH3 catalyst. This is unique in the
fact that it can show a potential interaction between the lipids that had not previously been seen
before.
Mixture with BF3
Systematic Name
Average
Retention
Time (min)

Formula

m/z

Shorthand
Designation

RSD Phospho

lipid
Source

19.415 ±
0.0060

Hexadecanoic Acid, methyl
ester

C17H34O2

270.2559

16:0

0.03% SM

23.552 ±
0.0148

15-Octadecanoic Acid, methyl C19H36O2
ester

296.2715

18:1

0.06% PC

Table 2-1. Mixture with BF3 FAME ID Table.

Mixture with NaOCH3
Systematic Name
Average
Retention
Time (min)

Formula

m/z

Shorthand RSD
Designation

Phospholi
pid
Source

19.432 ±
0.0218

Hexadecanoic Acid, 15methyl ester

C17H36O2

272.2715

16:1

0.11
%

PC

24.145 ±
0.0014

Octadecanoic acid, Methyl
Ester

C19H38O2

298.2872

18:0

0.01
%

PI

Table 2-2. Mixture with NaOCH3 FAME ID Table.

Beef Tissue:
Using Ground Beef tissue, the lipid extraction process succeeded in removing the lipids
from tissue for FAME esterfication. Utilizing both catalyst on the extracted lipids FAMES were
created for analysis by GC-MS. Many FAMES were found to be present with in the test sample,
but due to the retention time placement, and carbon length of particular FAMES a comparison to
the lipid standards was done. With the BF3 sample a maximum of two FAMES were identified to
have possible come from SM & PC (Table 3-1), with other FAMES from other lipids being
found present with in the sample, but with no standard to identify these particular FAMES. This
was not the case with the tissue lipid extracts with NaOCH3, where a majority of the FAMES
that were identified as being PC with only one peak being identified as PI, none as SM(Table 32). Although just as the BF3 sample there were other FAMES from lipids that were present
within the sample tested that could not be identified due to a standard not being available to
compare the retention time and carbon length.
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Tissue with BF3
Average Systematic Name
Retention
Time
(min)

Formula

m/z

Shorthand
Designation

RSD

RSD

Phosph
olipid
Source

19.413 ±
0.0072

Hexadecanoic Acid,
methyl ester

C17H34O2

270.2559 16:0

0.04%

0.04
%

SM

20.620 ±
0.0092

Dodecane, 1,1dimethyl-

C14H30O2

230.2246

0.04%

0.04
%

Other
lipid

23.543 ±
0.0010

16- Octadecanoic
acid, methyl ester

C19H36O2

296.2715 18:1

0.004%

0.004 PC
%

24.145 ±
0.0050

Undecanoic acid,
methyl ester

C12H24O2

200.1776 11:0

0.02%

0.02
%

Other
lipid

25.204 ±
0.0052

4,5 Bisdimethoxymethyloctanedioic acid,
dimethyl ester

C16H30O8

350.1941

0.02%

0.02
%

Other
lipid

RSD

Phosph
olipid
Source

0.05%

0.05

Other
lipid

0.05%

0.05
%

Other
lipid

Table 3-1. Tissue with BF3 FAME ID Table.
Tissue with NaOCH3
Average Systematic Name
Retention
Time
(min)

Formula

m/z

Shorthand
Designation

RSD

14.302 ±
0.0065

Methyl
Tetradecanoate

18.890 ±
0.0095

Unknown

19.418 ±
0.0065

Hexadecanoic acid,
methyl ester

C17H34O2

270.2559 16:0

0.03%

0.03
%

PC

23.516
±0.0551

9-Octadecanoic acid C19H36O2
(Z)-, methyl ester
(C19:1)

296.2715 18:1

0.23%

0.23
%

PC

24.142 ±
0.0044

Octadecanoic acid,
methyl ester

298.2872 18:0

0.02%

0.02
%

PI

C15H30O2

C19H38O2

242.2246 14:0

Table 3-2. Tissue with NaOCH3 FAME ID Table.

Conclusion
In conclusion, the GC-MS data showed that the FAME synthesis procedure worked in
creating methyl esters, for GC-MS analysis. The NaOCH3 catalyst being the better catalyst when
trying to analyze, PC & PI, whereas BF3 is the better catalyst when trying to analyze SM with the
17

GC-MS, to obtain the least amount of noise within the chromatogram. The lipid extraction from
the beef tissue was successful, with the NaOCH3 showing more lipids FAMES for identification
from standard comparison, than BF3. Due to the fact that the Relative Standard Deviation (RSD)
was below 1%, all tests were run with multiple runs having a little to no difference in retention
time placement.
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Fluorescence Labeling of cpSRP43 to Monitor the Protein
Structure by Single Molecule FRET
Jasmine Brown, Philander Smith College
Little Rock, Arkansas

Abstract
Various studies have been conducted to determine the structural changes of
chloroplast protein signal recognition particle 43 (cpSRP43) upon its interaction with
chloroplast protein signal recognition particle 54 (cpSRP54). These two proteins form a
heterodimer which transport the light harvesting chlorophyll binding proteins to the
thylakoid membrane to be used in photosynthesis. In this research, several methods were
used to optimize the fluorescence labeling of cpSRP43 with the dyes alexa488 and alexa546.
We used ensemble and single molecule Förster resonance energy transfer (FRET) to
determine the structural changes during the interaction between cpSRP43 and cpSRP54.
We were successful in establishing a labeling protocol that increased the concentration of
FRET labeled proteins and used single molecule FRET (smFRET) to show structural
heterogenity.

Introduction
Plants are efficient in converting sunlight into chemical energy which is essential for
every form of life. There are various proteins in the chloroplast that are responsible for
generating chemical energy. In our research, we are interested in the cpSRP43 and cpSRP54
proteins. cpSRP are chloroplast protein signal recognition particles that are used to transport light
harvesting chlorophyll a and b binding proteins to the thylakoid membrane (LHCP) (Stengel,
Holdermann, Cain, Robinson, Wild, & Sinning, 2008). cpSRP is formed by a combination of
chromodomains and ankyrin domains (Stengel, Holdermann, Cain, Robinson, Wild, & Sinning,
2008) (see figure 1). The cpSRP43 has four ankyrin sequential repeats that are involved in
protein-protein interactions and complex formation (Cain, Holdermann, Sinning, Johnson, &
Robinson, 2011).
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There
are
two
chromodomains CD2 and
CD3 which are located at the
C-terminal of the protein
(Cain, Holdermann, Sinning,
Johnson,
&
Robinson,
2011).There
is
one
chromodomain CD1 that is
located at the N-terminal
(Cain, Holdermann, Sinning,
Johnson, & Robinson, 2011).
cpSRP43 is also reported to
serve as a chaperone that
reverses the aggregation of its
substrates’ proteins (JaruAmpornpan, et al., 2010).
The actual structure of
cpSRP43 and cpSRP54 is
unknown although structures
of the individual CD1-Ank4,
CD2 and CD3 have been
K F Stengel et al. Science
deposited in the protein data
bank as 3DEO, IX3P, and
2008;321:253‐256 (3DEO in
IX3Q, respectively. The SRP
PDB) Figure 1
in cpSRP is a signal
recognition particle, cytoplasmic
ribonucleoprotein
that mediates GTP dependent
co-translational targeting of
proteins to the endoplasmic
reticulum (Schuenemann, et
al., 1998). The concentration
of cpSRP43 controls the
partitioning of cpSRP54
between co-translational and
post-translational mode of
targeting proteins in the
chloroplast (Kathir, et al.,
2008). The LHCPs of the thylakoid membrane are part of a hydrophobic family of proteins
involved in photosynthesis (Schuenemann, et al., 1998). LHCPs are part of the photosystem I
and II and are synthesized in cytosol (Cain, Holdermann, Sinning, Johnson, & Robinson, 2011).
The objectives for this research were to examine the structural changes of cpSRP43 upon
interaction with cpSRP54 to gain an understanding of how the cpSRP43 and cpSRP54
heterodimer binds to LHCP to transport it to the thylakoid membrane to be used in
photosynthesis. By understanding the transport mechanism our goal is to hopefully have an

CD3

CD2
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impact on the development of efficient solar energy devices. We would like to understand how
plants are capable of efficiently producing chemical energy from sunlight in particles how they
transport and insert the photosynthetic proteins. In this project, two mutant proteins were used in
the experiments. For one of the proteins, we labeled the ankyrin 2 and chromodomain 3 and is
referred to as protein 1 (P1). The other protein we labeled ankyrin 2 and chromodomains 2 and is
referred to as protein 2 (P2).

Experimental Procedures
Materials used for this research includes alexa488 maleimide (donor dye), alexa546
maleimide (acceptor dye), HKM buffer (Hepes, Potassium chloride, Magnesium chloride), PBS
buffer (Phosphate Buffered Saline), nano-pure water, Econo-column, Bio-gel P-6DG gel, urea,
cpSRP43, cpSRP54, and TCEP (Tris (2-carboxyethyl) phosphine). The equipment that was used
included the Ultraviolet visible spectrophotometer, fluorescence spectrometer, and the
Fluorescence microscope. The ultraviolet visible spectrophotometer measures the absorbance so
that the concentration of the donor and acceptor dyes relative to the protein concentration can be
determined to quantify the labeling efficiency. The fluorescence spectrometer is used to measure
the average fluorescence resonance energy transfer (FRET) for the sample (Skoog, Holler, &
Crouch, 2007). The fluorescence microscope is used to measure the single molecule FRET.
There were a series of experiments that were performed in order to optimize the labeled protein
that was used to determine single molecule Förster resonance energy transfer.
Protein Unfolding. The cpSRP43 was unfolded using urea concentration ranging from 0
molar to 8 molar. By conducting the unfolding experiments, the data revealed which urea
concentration could be used to unfold the protein so that the two cysteines can be exposed to the
fluorescent dyes for attachment. The urea was diluted in HKM buffer making an 8.6M stock urea
solution. It was added to a solution that contained the protein and HKM buffer. The stock
concentration of the protein was 4mM. The table below shows the how much of each solution
was added to each sample (Table 1). Unfolding was monitored by the fluorescence spectroscopy
(see later).

Sample

Stock protein
(mL)

1
2
3
4
5
6
7
8

2.5
2.5
2.5
2.5
2.5
2.5
2.5
2.5

Stock Urea
Concentration
(mL)
0
12.5
25
37.5
50
62.5
75
87.5

HKM Buffer
(mL)
97.5
85
72.5
60
47.5
35
22.5
10

Final Urea
Final Protein
Concentration Concentration
(nM)
(M)
100
0
100
1.08
100
2.16
100
3.24
100
4.32
100
5.40
100
6.48
100
7.56

Table 1

Labeling cpSRP43 proteins. Proteins 1 and 2 were labeled with thiol reactive ATTO
labels (maleimides). The fluorescent dyes that were used were alexa488 and alexa546
(Invitrogen). For this experiment, the materials HKM buffer, urea, and TCEP were used. We
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added 10 micro liters of 10x PBS buffer, 5 micro liters of TCEP reagent, and 47.5 micro liters of
nano-pure water to an eppendorf tube. TCEP is used to ensure the thiol remains as its reduced
(SH) form. After the solution has been mixed, the protein is added to the solution. After allowing
the solution to react for ten minutes, we added the 2.5 micro liters of 1mM alexa546 and 5 micro
liters of 1mM alexa488. The mixture was covered with aluminum foil to protect it from any
source of light in the room and allowed to react overnight. This method was repeated several
times with different dye concentrations, time elapsed between adding the alexa546 and alexa488,
and the addition of urea to unfold the protein to increase labeling. The maleimide chemistry
(figure 2) and labeling protocol (table 2) is shown in the figures below.
O

Fluorescent
dye

N

+

cpSRP4

HS

O

Chloroplast protein

O
S
Fluorescent
dye

cpSRP4
N

O
Fluorescent labeled protein
Figure 2
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Components

Method 1

Method 2

Method 3

Method 4

1 mM

3 mM

3 mM

3 mM

1 mM

1 mM

3 mM

3 mM

Add Urea

No

No

No

Yes

Time Elapsed
Between
adding
Alexa546 and
Alexa488

0 hours

2 and 6 hours

1 hour

1 hour

Alexa546
Concentration
Alexa488
Concentration

Table 2

Gel filtration. A gel column is used to separate proteins, peptides, and oligonucleotides based on
size (Gel Filtration Chromatography, 2011). The smaller molecules are trapped in the gel while
the larger molecules move quickly through the column (Gel Filtration Chromatography, 2011).
We used HKM buffer, Bio-gel, and Econo-column. The Bio-gel was packed into a glass econocolumn using the eluent, HKM buffer. The sample was added to the top of the Bio-gel and eluted
down the column. The sample separated into two distinct bands. The first band contained the
labeled proteins while the second band contained the excess dyes. Fractions were collected from
the column as the sample was filtered through the gel. The first band was collected in an
eppendorf tube and separated from the excess fluorescent dye band. The formation of the bands
formed during size elusion chromotagraphy is shown in figure 3.

Excess dyes

Labeled
protein

Figure 3

Fluorescence and absorbance spectra. The fluorescence and absorbance is measured
and recorded for each fraction using the fluorescence spectrometer (Perkin Elmer LS-50) and
ultraviolet visible spectrophotometer (Hitachi U3900H), respectively. The HKM buffer was used
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as the baseline when the absorbance was measured. The parameters for measuring the
absorbance included start at 800 nanometers, end at 200 nanometers, and a speed of 600
nanometers per second. The absorbances were recorded at 280 nm for the protein, 499 nm for the
donor dye, 558 nm for the acceptor dye, and 700 nm for the background. From these
absorbances, the labeling ratio was calculated.
To calculate the labeling ratio we used the following equation:

A is the absorption that is measured at wavelengths 280 nm for the protein, 499 nm for the donor
dye, and 561 nm for the acceptor dye. The epsilon is the extinction coefficient for each species.
The epsilon value for the protein at 280 nm is unknown but estimated to be about
20,000
. For the donor at 499 nm, the epsilon value is 71,000
. For the
acceptor at 561 nm, the epsilon value is equal to 104,000
. B is the length of the
cuvette, 1 cm.
To calculate the labeling ratio, we collected the absorption values for the wavelengths.
The absorption values at 280nm, 499nm, and 561 nm are corrected using the background
absorption value from the wavelength of 700 nm due to spectral overlap. The alexa488
absorption is corrected by subtracting 15% of the alexa546 absorption at 561 nm. Protein
absorption is corrected by subtracting 14% of alexa546 absorption at 558 nm and 12% of
alexa488 absorption at 499 nm.
The fluorescence spectrometer was used to measure the protein, donor fluorescence, and
acceptor dye fluorescence for the sample. It is used to calculate the average FRET for a sample
using the following equation.

The fluorimeter can also be used to determine the protein unfolding monitoring the
tryptophan fluorescence. The parameters for the tryptophan fluorescence included start at 300
nm, end at 500 nm, excitation at 280 nm, scan speed at 200 nm per second, excitation slit at 10
nm, and the emission slit at 10 nm. The donor dye parameters included start at 505 nm, end at
700 nm, excitation at 485 nm, scan speed at 300 nm per second, excitation slit at 10 nm, and
emission slit at 10 nm. The acceptor dye parameters included start at 560 nm, end at 700 nm,
excitation at 540 nm, scan speed at 300 nm per second, excitation slit at 10 nm, and emission at
10 nm.
Single molecule Förster Resonance Energy Transfer. The equipment used was the
fluorescence microscope. Single molecule FRET (smFRET) is used to measure fluorescence
intensity of the donor and acceptor fluorescence of a single molecule. The FRET is sensitive to
the distance between the dyes and therefore, protein structure. And can be used to determine if
there are any structural changes in the single proteins. The sample has to be diluted a hundred
times so that the fluorescence of one molecule can be detected. The laser intensity is 610.83
arbtitrary units which equals about 30 mW and ten traces are collected in two minute intervals.
The FRET efficiency of each molecule is calculated using the equation:
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E stands for FRET efficiency value (Kuzmenkina, Heyes, & Nienhaus, 2005). and
are the acceptor and donor fluorescence intensities (Kuzmenkina, Heyes, & Nienhaus, 2005).
The gamma is used to correct the different detection efficiencies and the quantum yields of the
two dyes (Kuzmenkina, Heyes, & Nienhaus, 2005) and has a value of 0.5.

Results and Discussion
Protein unfolding. With the collected data, we were able to identify that the protein
unfolded at urea concentrations of about 3M so that any buried cysteine residues will be exposed
to the dyes at urea concentration greater than 3M. Figure 4 (left) shows that as urea is added to
the protein, the wavelength of tryptophan emission shifts from 345 nm to 356 as the protein
unfolds. Using the graph on the left, we composed a graph that shows the unfolding curve.
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Trp fluorescence spectra peak position (nm)
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p2_2M
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0

p2 urea unfolding curve
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350
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340

300

350

400
Wavelength (nm)

450
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0

1

2
3
4
Urea concentration (M)

5

6

Figure 4

Protein labeling and gel filtration. The methods were consistently modified in order to
decrease the number of donor only labeled proteins and to increase the number of the FRET
labeled proteins. After collecting fractions from the gel filtration, we determined that fraction
three contained the proteins that were attached to the dyes. There are eight possible outcomes
when labeling proteins with fluorescent dyes. The protein can be single labeled with just one
donor dye or one acceptor dye. The protein can also be double labeled with two of the same dyes
attached the cysteines on one protein. The other possibility is the FRET labeled protein which
has one of each dye attached to the cysteine groups located on the protein. The graph below
(figure 5 left) is the absorbance spectrum that was obtained from the UV visible
spectrophotometer after gel filtration. The absorbance spectra shows the peaks of the labeled
proteins at the wavelengths 280 nm, 499 nm, and 561 nm which is located between eluted
volumes 1 and 2. The peak at elute volume 3 mL shows the absorbance peak for the acceptor dye
at wavelength 561 nm. The peak located between 4 and 5 shows the absorbance peak of the
alexa488 at the wavelength 499 nm. This data shows the data from method 4. The graph to the
right (figure 5 right) shows the absorbance peaks from protein 1 fraction 3 that were used to
determine the labeling ratio which is shown in the table 3. The peaks in this graph also represent
the wavelengths at 280 nm, 499 nm, and 561 nm for the fraction that contained the labeled
protein.
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Labeling ratios

Method 1

Method 2

Method 3

Method 4

1 : 0.3 : 0.6

1 : 0.06 : 0.9

1 : 0.6 : 1.3

1 : 0.56 : 1.2

Table 3

The labeling ratio is a comparison of the protein concentration to the concentration of
donor and acceptor labels. The labeling ratio in methods 1 and 2 were too low in value to note
any significant changes that occurred by modifying the labeling protocol. In method 1, the dye
concentrations were the same and they added simultaneously. The concentration of donor only
labeled and acceptor only labeled proteins were relatively low because the dye concentrations
were competing to attach to the cysteine group. There was also a low level of FRET labeled
proteins (see later). By tripling the alexa546 concentration compared to the alexa488
concentration and increasing the time elapsed between adding the dyes in method 2, the
concentration of acceptor labeled increased and the concentration of donor labeled proteins
decreased. In method 3, dye concentrations were the same and the time elapsed between adding
the dyes was decreased to an hour. There was a significant increase in the concentration of both
donor and acceptor labeled suggesting more FRET labeled protein. In an effort to decrease the
donor-only labeled protein, urea was added to the aqueous solution before adding the dyes in
method 4. This slightly decreased the donor only labeled protein.
Fluorescence Spectroscopy to measure average FRET. By increasing the alexa546
concentration to 3 mM and waiting for an hour before adding 1.5 mL of 3mM alexa488, we
increased the concentration of proteins that were labeled with both fluorescent dyes. The dotted
lines represent the direct excitation of the acceptor with 485 nm light in both of the graphs below
that show the average FRET for the labeled sample. By measuring the FRET efficiency of each
protein (P1 and P2) before and after adding cpSRP54 we found that the FRET efficiency
increased for P2 but not for P1 upon addition of cpSRP54 (table 3).
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Without urea
Without
cpSRP54
P1
P2

With urea

With
cpSRP54

0.46

0.47

0.42

0.51

Without
cpSRP54
0.56
0.54

With
cpSRP54
0.59
0.67

Table 4
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Single molecule FRET. Figure 7 shows the single molecule burst data of the single proteins
labeled with the alexa488 and alexa546 dyes obtained from the fluorescence microscope. The
peaks that are above the horizontal axis at zero represent the intensity of the donor dye alexa488
(red). The peaks that below the horizontal axis at zero represent the intensity of the acceptor dye
alexa546 (blue).
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-100
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Figure 7

These intensities from each burst (single molecule) can then be substituted into the FRET
efficiency equation below

The proteins labeled only with acceptor do not have any significance in the FRET
histograms because the lasers that are used during the smFRET do not excite the acceptor dyes.
The donor only labeled proteins are detected in the FRET histogram as a peak centered at zero
FRET.
The graphs below show the data that was obtained from the single molecule FRET
measurements for method 3 without urea (figure 8) and method 4 with Urea (Figure 9). The first
peak (in green) represents the donor-only labeled protein. The data shows that the addition of
cpSRP54 increased the FRET efficiency for peak 4 (high FRET) in both protein 1 and protein 2,
although to a much lower extent in protein 1. Peaks 2, 3, and 4 in the histogram suggests that at
least three distinct states of cpSRP43 are present, which can only be observed in the smFRET
experiment.
The data showed that the ensemble fluorescence and smFRET are consistent in
measuring the average FRET of the two protein samples. That is to say that the average FRET
efficiency for P1 and P2 are similar, but that the average FRET efficiency for P2 increases with
the addition of cpSRP54, whereas it increases only slightly for P1
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Figure 8
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Figure 9

Comparing figure 8 and 9 shows that the addition of the urea during the labeling reaction
increased in the amount of FRET-labeled proteins, and decreased the donor-only labeled
proteins, which was a major objective of this project. This reduction in the donor-only peak
allows for less interference (and therefore more confidence) in determining the FRET
efficiencies and populations of the different protein states. Furthermore, since the difference
between the FRET efficiency in protein 1 and protein 2 upon addition of cpSRP54 was identical
from both labeling methods (3 and 4), this shows that using urea for labeling did not permanently
affect the protein structure but did help in reducing the donor-only peak.
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Conclusion
Urea concentrations above 3M unfolds the protein and exposes both of the cysteines on
the protein to the fluorescent dyes more so than the cysteines in the folded protein. By modifying
the labeling protocol to add urea when the donor dye is added, the concentration of FRET
labeled proteins increased, and the concentration of donor-only proteins decreases. Since both
proteins P1 and P2 were improved by adding urea, and the cysteine group that is common
between P1 and P2 is in the Ank2 domain, this suggests it is this ankyrin 2 cysteine that is
difficult to label, possibly the cysteine residue is not exposed to the solvent when the protein is
folded. This result highlights the importance of optimizing the labeling protocol for efficient
labeling of cpSRP43 for FRET studies.
The smFRET data showed that there are various states of cpSRP43. The population of
these states changed as cpSRP54 was added – the higher FRET state was more prevalent when
cpSRP54 was present. The differences in the smFRET histograms between Ank2-CD2 and
Ank2-CD3 labeled proteins upon the addition of cpSRP54 suggest that cpSRP54 interacts
differently with CD2 than CD3. The reasons for these differences are not yet clear, but will be
the focus of continued studies. For example, future goals will be to investigate the labeling of a
mutant where the cysteines are placed in CD2 and CD3 and deleted from Ank2. The
optimization of the labeling protocols described in this report will be invaluable in obtaining high
FRET labeling efficiencies and reducing donor-only peaks for future cpSRP43 mutants.
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Synthesis and Characterization of a Ru-Pd Bimetallic Complex
Ryan Christman, Ohio Northern University
Ada, Ohio

Abstract
Despite its recent implication as the active catalyst in direct arylation via C-H
functionalization, little is known about the properties and reactivity of Pd(III). To address
this lack of knowledge, Dr. Zheng devised a bimetallic ruthenium-palladium model to
study Pd(III). This paper details the synthesis of one of the ligands for this complex.

Introduction
The area of green, or sustainable, chemistry has become a major research focus as
scientists try to make improvements for humans and our environment. Direct arylation via C-H
functionalization is a specific area within green chemistry that has many advantages over current
synthesis methods. By performing chemistry directly on carbon-hydrogen bonds, the need for
pre-functionalized groups is eliminated. This allows for developing more efficient synthetic
methods, eliminating waste and saving time and money.
Transition metals are often required to functionalize inert C-H bonds, the most common
being ruthenium, rhodium, and palladium. A Pd(II)-Pd(IV) redox cycle is typically invoked as
the accepted mechanism involving palladium as the catalyst for C-H functionalization. Recently
though, Pd(III) has been shown to be the active catalyst in direct arylation reactions by Ritter and
Sanford.3,6 While the reactivity of palladium in its second and fourth oxidation states is well
understood, palladium in its third oxidation state, only recently being recognized in
organometallic reactions, has not been studied extensively. Unlike Pd(IV), which has a
monomeric octahedral geometry, Pd(III) adopts a dimeric octahedral geometry.7 Reductive
elimination, the final step in Pd-catalyzed direct arylation, could be greatly affected by this
geometry difference between Pd(III) and Pd(IV).
In order to address this lack of knowledge, Dr. Zheng devised a bimetallic rutheniumpalladium model to specifically study palladium in its third oxidation state. Since the electron
transfer between Ru(II) and Ru(III) is strictly a one-electron process, only the desired Pd(III)
complex is expected to be formed. The mononuclear Pd(III) complex is expected to be an
unstable and short-lived species. Also, preparation of Pd(III) is usually accomplished by
oxidation of Pd(II) with an external oxidant that is usually incorporated into the final product.
Discovery of a milder and innocent oxidant would be a major help in broadening the application
of Pd(III)-catalyzed direct arylation. By using complex 1.11 as a model, we hope to be able to
study Pd(III) and address these issues. Through flash photolysis, Ru(II) is easily oxidized to

33

Ru(III) in the presence of viologen. Then Ru(III) should oxidize Pd(II) to Pd(III), while
itself is reduced to Ru(II). This electron transfer process involving the Ru(II) to Ru(III) metal
center has been extensively used to study electron transfer reactions in biological systems by
Durham.4

Figure 1. Synthesis Scheme for Ru-Pd complex

Experimental Procedures
All reactions were carried out under an inert atmosphere, mostly nitrogen. Purification
was done using flash chromatography or distillation and products were characterized by NMR.
A) 1.1: Triethyl phosphonoacetate (20.1 mL) was added to NaH (4.34 g) in THF (97 mL)
at 0°C. Let warm to room temperature and stir for 30 minutes. Dissolve 2-bromobenzaldehyde
(7.9 mL) in THF (97 mL) in a separate flask. Add the solution of 2-bromobenzaldehyde to
triethyl phosphonacetate mixture at 0°C. Stir for 20 minutes at 0°C, then let warm to room
temperature and stir for 1 hour.
Cool to room temperature and add neat triethyl
phosphonoacetate (4 mL), then NaH (0.872 g). Stir at 0°C for 20 minutes, then let warm to room
temperature and stir for 1 hour. Quench it with saturated NH4Cl (12 mL) and H2O (10 mL).
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Extract aqueous layer with EtOAc (2×10 mL). Washed with H2O (10 mL) and brine (10 mL).
Concentrate and distill off excess triethyl phosphonoacetate by high vacuum. Yield: 6.20 g
(36%). 1H NMR: CH3, 1.34 (t); CH2, 4.29 (q); CH, 6.39 (d); aromatic, 7.19-7.10; CH, 8.05(d).
B) 1.2: Make slurry of LiAlH4 (1.24 g) in THF (63 mL). Dissolve 1.1 (2.80 g) in THF
(63 mL). Place LiAlH4 slurry in an ice/methanol bath and add 1.1 via syringe. Stir for 1 hour in
bath. Warm to room temperature and stir for 1 hour. Add H2O (1.3 mL), NaOH (1 mL), and
H2O (3.6 mL). Filter through celite with EtOAc and concentrate. Yield: 1.92 g (82%). 1H
NMR: CH2, 1.89(quintet); CH2, 2.81(t); CH2, 3.69(t); aromatic, 7.05-7.58.
C) 1.3: Add 2-bromopyridine (2.2 mL) and triisopropyl borate (5.8 mL) to 4:1 mixture of
toluene (90 mL) and THF (23 mL). Cool to -78°C and added 16 mL of n-BuLi over 30 minutes
via syringe pump. Stir at -78°C for 30 minutes, then let warm to room temperature. Concentrate
and dry under vacuum at 110°C for 4 hours. Yield: 5.10 g (83%).
D) 1.4: Add 1.3 (3.24 g), Pd(dppf)Cl2 (0.145 g), and CsCO3 (2.57 g) to a schlenk flask
with a side arm. In glove box, add ZnCl2 (.539 g) and CuCl (.034 g) to the flask. Dissolve 1.2
(.848 g) in DMF (40 mL) and transfer to the flask. Degas the flask via freeze, pump, thaw for
three cycles. Stir at 110°C for 19 hours (closed system). Filter through celite with EtOAc and
concentrate. Yield: 0.442 g (53%). 1H NMR: CH2, 1.96(quintet); CH2, 2.85(t); CH2, 3.52(t);
aromatic, 7.20-8.69.
E) 1.5: Added Dess-Martin Periodinane (1.44 g) to a flask. Dissolve 1.4 in CH2Cl2 (16
mL) and transfer to the flask. Stir at room temperature for 48 hours. Dilute with EtOAc (30 mL)
and partition with 1:1 saturated Na2S2O3 : saturated NaHCO3 (30 mL). Extract with EtOAc
(2×15 mL). Wash with H2O (15 mL) and brine (15 mL) and concentrate. Yield: .183 g (42%).
1
H NMR: CH2, 2.70(t); CH2, 3.04(t); aromatic, 7.17-8.69; CH, 9.69(s).
F) 1.7: Mix 1.6 (.401 g) in 48% HBr (8 mL) and concentrated (98%) H2SO4 (0.8 mL).
Reflux for 3 hours. Neutralize with saturated Na2CHO3 and filter. Dissolve product in EtOAc
and washed with brine. Dry over Na2SO4 and concentrate. Immediately start next step. Crude
Yield: .365 g (69%)
G) 1.8: Added neat triethyl phosphite (1.5 mL) to crude 1.7. Stir at 80°C for 6 hours.
Distill excess triethyl phosphite. Crude Yield: .460 g (103%). 1H NMR: CH3, 1.27(t); CH3,
2.43(s); CH2, 3.22(d); CH2, 4.09(quintet); aromatic, 7.11-8.59.
H) 1.9: Add KOtBu (.0818 g) to THF (0.5 mL) in glove box. Dissolve 1.8 in THF (0.5
mL). Transfer 1.8 to KOtBu at 0°C and wash with THF (0.5 ml). Stir at 0°C for 30 minutes.
Dissolved 1.5 (.051 g) in THF (0.5 mL). Transfer 1.5 to the flask with 1.8 and wash with THF
(0.5 mL). Warm to room temperature and stir for 3 hours. Quench with H2O (4 drops). Filter
with EtOAc. Partition with H2O (added 1 mL of Hexanes for better partition). Wash with H2O
(5 mL). Extract with EtOAc (3×5 mL). Wash with brine (5 mL) and concentrate. Crude Yield:
.0478g (53%). 1H NMR: CH3, 2..43(s); CH2, 2.56(q); CH2, 2.84(t); CH, 6.19(q); CH, 6.29(d);
aromatic, 6.94-8.78.
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Figure 2. a) 1H NMR of 1.8 b) 1H NMR of 1.9 with leftover
starting material 1.8
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Results and Discussion
Problems with the original synthetic scheme prevented us from completing the synthesis
of complex 1.11, and we were able to get as far as synthesizing 1.9. The first problem was with
the Suzuki Miyaura Cross-Coupling. Initial attempts using Pd2(dba)3 and diphenylphosphine
oxide as the catalyst resulted in no reaction. Upon switching to the catalyst system composed of
Pd(dppf)Cl2, ZnCl2, and CuCl, 1.4 was obtained in 38% yield on the first attempt, and 53% on
the second attempt. Oxidation of 1.4 to aldehyde 1.5 also presented problems, as the Swern
Oxidation yielded only 32%. Dess-Martin Oxidation yielded a slightly improved 42%.
Synthesis of 1.8 worked well, with an overall yield of 72%. Problems again arose with the
Horner-Wadsworth-Emmons Olefination as original attempts using KHMDS as a base yielded
mostly one of the starting materials, phosphonate 1.8 while the other starting material, aldehyde
1.5 decomposed. When KOtBu was used instead, we were able to synthesize 1.9, but attempts to
purify it from starting material 1.8 using flash chromatography were unsuccessful, as Figure 2
demonstrates.

Conclusion
Synthesis of ligand 1.9 was successful. The problem with purification of 1.9 could be
easily fixed by using a slight excess of aldehyde 1.5 compared to phosphonoacetate 1.8, as 1.5
should be easily separated using flash chromatography. As both the ruthenium and palladium
metal centers have been extensively studied, we anticipate that steps I and J should be
uneventful, leading to the synthesis of bimetallic complex 1.11.
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Expression and Purification of Cdc42 and PBD46, a Cancer-Causing
Combination
Edward Evans Jr., Wabash College
Crawfordsville, Indiana

Abstract
The Ras superfamily consists of low molecular weight G-proteins that are heavily
involved in cellular signaling, leading to various downstream responses. Like other Ras
proteins, Cdc42 (cell division cycle 42) acts as a molecular switch interchanging from its
active (GTP-bound) and inactive (GDP-bound) state through the utilization of GAP
(GTPase-activating proteins) and GEF (guanine nucleotide exchange factors) effectors (See
Figure 1). It has been shown that Cdc42 signaling pathways play a major role in cell
proliferation and differentiation leading to tumor growth. PBD46 is an effector of Cdc42
proven to inhibit GTP hydrolysis, stabilizing the Ras protein in its active state. PBD46, as
well as many other effectors, bind to the Switch I region (amino acids 28-40) of Cdc42. By
site-directed mutagenesis, threonine of position 35 was replaced with alanine forming a
Cdc42 mutant. With the use of affinity column chromatography, Cdc42(wild type),
Cdc42(T35A), and PBD46 were expressed and purified for future tests of the Switch I
binding interface.

Figure 1. The Cdc42 cycle. Cdc42 interchanges from active and inactive states. Other proteins
of the Ras superfamily behave similarly.

Introduction
Cell division cycle 42 (Cdc42) is a member of the Rho subfamily of small GTPases.
Typical of Rho proteins, members of this family are heavily involved in cellular activity via
signal transduction resulting in downstream responses. Most notably, these responses lead to
cell proliferation, morphogenesis, and cytoskeletal changes. Cdc42 functions as a molecular
switch, cycling between inactive (GDP-bound) and active (GTP-bound) state. This interchange
is influenced by guanine nucleotide-exchange factors (GEFs), which replace GDP with GTP on
39

Cdc42, and GTPase-activating proteins (GAPs), which promote GTP hydrolysis to its inactive
form. In its inactive state, Cdc42 is not effectively performing signal transduction; however,
when bound to GTP, Cdc42 can bind to various other effectors, causing downstream signaling.
P21 Binding Domain (PBD46) is a 46-amino acid derivative of a p21 activating kinase
(PAK). It has been shown that Cdc42 has a high affinity for PAKs. Particularly, PBD46 inhibits
the GTP hydrolysis of Cdc42, keeping the protein in its active state and enabling the downstream
signaling that leads to the formation of tumors. Therefore, producing the Cdc42-PBD46
complex allows a means to investigate Rho proteins’ effect on cancer.
Furthermore, it has been found that PBD46 binds to Cdc42 in its Switch I region, amino
acids 28-40 (See Figure 2). It has been documented that threonine is consistently 35th in Rhorelated proteins, indicating that this amino acid is critical for proper function of Cdc42. The
threonine was mutated to alanine to determine differences in the binding interfaces of
Cdc42(wild type) and Cdc42(T35A). This will help determine the purpose of threonine’s
consistency in Ras proteins. Proper expression and purification of Cdc42(WT), T35A, and
PBD46 will enable future tests to compare and contrast the wild type and mutant’s binding
capabilities.

Figure 2. The first 50 amino acids of Cdc42. The Switch I region is where PBD46 binds to the
Ras protein. Threonine has been mutated to alanine, making T35A.

Materials and Methods
Protein Expression Cdc42 is expressed in E. Coli strain BL21(DE3) from pET-15b
vectors as a hexa-histidine tagged protein. For large scale expressions, Cdc42 was grown in 500
mL of LB with 0.1 mg/mL ampicillin (same concentration for all LB samples) overnight at 37
°C. Six flasks of 1.5 liters of LB each were inoculated with 75 mL of the seed culture. The fresh
cultures were allowed to grow to an optical density at 600 nm (OD600) in the range of 0.4 – 0.6.
Ideally, this takes approximately 1 to 1.5 hours. The cultures were induced with1.0 mM
isopropyl β-D-thiogalactopyranoside (IPTG) and allowed to incubate for 3.5 hours at 37 °C.
Then, the cells are centrifuged at 6500 rpm for 15 minutes at 4 °C and washed with a 40 mM
Tris-base solution. The cells are centrifuged again, and the pellet is stored at -80 °C until
needed.
Before and after induction, 1 mL aliquots were taken from each flask. These cells were
spun down by centrifugation at 14000 rpm for 15 minutes at 4 °C. The pellet was resuspended
with 120 µL of 8 M urea and stained with 40 µL of 4x loading dye. The aliquots were incubated
at 90 °C for 2 – 5 minutes and stored at 4 °C afterwards. These aliquots were designated for gel
electrophoresis on 15% sodium dodecyl sulfate (SDS) gels.
Cdc42(T35A) was expressed in the same manner, but PBD46 had alterations. PBD46 was
allowed to grow to an OD600 range from 0.8 – 1.0. Induction was allowed to transpire for 4 to 5
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hours. Finally, the PAK was washed with PBS buffer (0.14 M NaCl, 0.0030 M KCl, 0.01 M
Na2HPO4 x 7 H20, 0.0018M KH2PO4 at pH 7.3) instead of a Tris-base solution.
Prior to large scale expression, test expressions were performed to guarantee that the
protein of interest was produced effectively. This entails a 10-mL overnight culture of protein
with ampicillin and an inoculation of 500 µL into fresher LB. After uninduced and induced
samples are taken, the cultures can be properly discarded.
Protein Purification Procedures are performed on ice unless otherwise indicated. The
stored pellet of Cdc42 was resuspended in a lysis buffer (30 mL Tris binding buffer, 30 mg
lysozyme, 300 µL Halt Protease Cocktail, 3.5 mg PMSF, with 1 mM GDP per liter of culture
being resuspended). Sonicate on ice 5 times for 20 seconds with 1-minute rest periods. The
cells were incubated on ice for 30 minutes with occasional stirring. A small amount of DNase is
added to the cells, and they incubate at room temperature for 15 minutes. The cells are
centrifuged at 19500 rpm for 15 minutes at 4 °C, separating the lysate and pellet. The lysate is
filtered, and aliquots of both the supernatant and pellet are taken. The lysate of Cdc42, being
kept on ice, is ran over a nickel affinity column on the fast protein liquid chromatography
(FPLC) machine with Tris binding buffer for nickel column purification (0.040 M imidazole,
0.100 M NaCl, 0.050 M Tris-HCl, 0.010 M MgCl2 x 6H2O at a pH of 8.0). The column is coated
with nickel ions, so the hexa-histidine tag of Cdc42 can bind to it. After running the lysate, the
higher concentration of imidazole in the elution buffer (0.250 M imidazole, 0.100 M NaCl, 0.050
M Tris-HCl, 0.010 M MgCl2 x 6H2O at a pH of 8.0) allows for Cdc42 to be purified. Fragments
from the suspected Cdc42 absorbance peak are collected for dialysis. A dialysis (molecular
weight cut off = 6-8 kDa) of the purified Cdc42 in 5 liters of Tris binding buffer was allowed to
spin overnight at 4 °C, removing final traces of impurities. The following day, the absorbance at
280 nm was taken and the protein concentration of the purified protein was determined using
Beer’s law. The protein is stored at -80 °C until needed.
Cdc42(T35A) is purified in the same manner. The general method of purification is the
same for PBD46, but there are numerous differences. For PBD46, 30 mL of PBS buffer is used
for the lysis buffer instead of Tris binding buffer. Also, GDP is not added. Since PBD46 is
GST-tagged, the column for PBD46 is a glutathione column, allowing the protein to bind via
disulfide bonds. The GST-tag must be removed if PBD46 is to form a stable complex with
Cdc42. Therefore, after purifying PBD46-GST with GST elution buffer (0.020 M Tris-HCl,
0.010 M reduced glutathione), the protein is put back on a glutathione column. Thrombin is
added to cleave the tag and allowed to rock overnight. Once the thrombin and PBD46 are
washed out of the column, the sample solution flows over a heparin column, allowing the
removal of thrombin. The purified PBD46 is dialyzed overnight in 5 liters of PBS buffer every
time it goes across a column. The concentration of the protein is determined by taking the
absorbance and using Beer’s law. PBD46 is also stored at -80°C until needed.

Data Collection
To verify that the protein of interest was actually expressing, gel electrophoresis of 15%
SDS gels were performed. SDS gels consist of stacking and separating segments utilized to
separate proteins based on their size. Their ingredients include acrylamide, water, SDS,
tetramethylethylenediamine (TEMED), ammonium persulfate, and a Tris buffer of pH 8.8 for the
stacking gel and pH 6.8 for the separating gel. All samples are run alongside a molecular weight
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marker ranging from 17 to 175 kilodaltons (kDa). This allows experimenters to approximate the
molecular weight of expressing proteins.

Results and Discussion
Purification of Cdc42 After the concentration of imidazole was increased on the nickel
column, an absorbance peak is observed at fragments A4-A7 for the wild type protein, as shown
in Figure 3. This is suspected to be Cdc42(WT), so samples of each fragment were taken for gel
electrophoresis. Cdc42 is approximately 21 kDa. As indicated on the SDS gel, the samples
corresponding to the suspected absorbance peak contain proteins of about 21 kDa. Furthermore,
the significant difference between the lysate and the flow through is also at 21 kDa as expected.
This verifies that Cdc42(WT) has, in fact, been purified.
As indicated above, the T35A mutant is expressed and purified in the same fashion as
that of the wild type. Two lysates of the mutant were put on the same column, consecutively.
When the concentration of imidazole was increased, the T35A absorbance peak is visible on both
chromatograms as expected. Both absorbance peaks corresponds to fragments A5-A9, which are
sampled on the SDS gel. The bands for the pools before and after dialysis indicate that the
protein is about 21 kDa. Once again, the most notable difference between the lysate and the flow
through is a band of approximately 21 kDa. This leads to a comfortable declaration that T35A
has also been purified.
Purification of PBD46 Altogether, PBD46 goes across 3 columns for purification. In
Figure 5, there is a chromatogram of the final step of purification on the heparin column.
Considering that PBD46 does not have a notable affinity to heparin, it begins to elute instantly in
fragments A2-A5. However, concluding that PBD46 has been purified cannot be confirmed with
the molecular weight marker used. The smallest shown band on the ladder is 17 kDa, but PBD46
is only 5 kDa. Although a significant band is shown well below the 17 kDa marker, it is not
reliable to assume this is the desired protein. The sample was sent in for MALDI mass
spectroscopy, but no traces of PBD46 were found.

Figure 3. Chromatogram and SDS gel of Cdc42(WT) purification.
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Figure 4. Chromatograms and SDS gel of Cdc42(T35A) purification.

Figure 5. Chromatogram of Heparin column and SDS gel of PBD46 purification.

Protein Concentration After dialysis, the protein concentration of the wild type, the
mutant, and PBD46 was determined by taking the absorbance at 280 nm of diluted samples.
Using Beer’s law, the protein concentration was extrapolated from the absorbance values. The
concentrations for Cdc42(WT), T35A #1, T35A #2, and PBD46 were 10.7 mg/mL, 2.2 mg/mL,
0.5 mg/mL, and 0.1 mg/mL, respectively.

Conclusion
With the use of affinity column chromatography, both Cdc42(WT) and T35A have been
expressed and purified in sufficient amounts to perform assays in the future. However, there is
not enough evidence to conclude that PBD46 has been properly isolated. Even so, 0.1 mg/mL is
not sufficient to perform a reasonable number of experiments.

Future Work
It is essential to purify PBD46 in sufficient amounts to perform experimentation on
Cdc42 activity. Ideas for optimizing the isolation of this effector have already been conjured. A
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different buffer for the lysis of cells and overnight dialysis may present a better yield. PBS
buffer has a pH of 7.3. However, this pH may be unsuitable for the protein. Also, it may be
favorable to use gel beads rather than pre-packed columns. This will allow for better thrombin
cleavage.
After effective purification of the proteins, isothermal titration calorimetry and
fluorescence tests may be performed to determine thermodynamic data regarding the binding
affinity of Cdc42 to PBD46. This will enable affinity comparisons of the Switch I region with
and without threonine in the 35th position.
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Redox-Magnetohydrodynamic Microfluidics Using Multiple Electrode Pairs
and Sweep-Step Potential Waveforms
Elaine Haas, Spring Hill College
Mobile, Alabama

Abstract
Microfluidics is integral for automating lab-on-a-chip (LOAC) devices, especially if
it is possible to program fluid flow. Redox-magnetohydrodynamics (MHD) offers unique
fluid control for LOAC devices, which is not possible with existing microfluidic pumps.
The MHD array setup induces fluid flow while eliminating the need for channels, thus
reducing the complexity of the detection system. This project addresses a complication
associated with redox-MHD: the need for the presence of redox species. In order to
minimize interference with a sample and detection, a strategy to immobilize them to the
electrodes was investigated. The redox species, hexamine ruthenium chloride, was tethered
to the electrodes using the polymer Nafion. Characterization with cyclic voltammetry
showed that the positively-charged redox species indeed loaded into the negatively-charged
Nafion polymer (through electrostatic interactions). Because there is a finite number of
redox species at the modified electrodes, they will deplete quickly under electrolysis
conditions. Thus, a method of redox replenishment was also investigated, but with redox
species in solution for preliminary studies (0.1 M potassium ferricyanide, 0.1 M potassium
ferrocyanide in 0.1 M potassium chloride). A chip was used with an array of individuallyaddressable microelectrodes to serve as the anodes and another array to serve as the
cathodes. With a multipotentiostat, different pairs of anodes and cathodes were activated
with a stepped potential (0 V to 0.3 V at the working electrode). Then at 0.220 s, one set
underwent a sweep which reversed its potential (in one experiment, a fast sweep over 0.220
s was used, and in another case a slow sweep over 0.660 s was used). The sweeps
replenished the redox species to their original state. This sequence was performed for 6
cycles. The fluid speed was twice as great with both sets during the potential step than
when one set was swept back. The results are encouraging that recovery of redox species in
this manner should be possible. In the future, the plan is (using another instrument) to
program a potential waveform using two or more separate active redox-modified electrode
pairs with the waveforms out of phase of each other, in order to produce a continuous fluid
flow, without interference of redox species with the sample.

Introduction
There is great interest in microfluidics and LOAC devices that allow for chemical
analysis on a miniature scale, thus reducing time, materials and power compared to benchtop
analysis. Microfluidics is concerned with the control and behavior of liquids that are entrapped
in a very small area. These fluids exhibit entirely different properties and behaviors than do
fluids on a large scale.
This project investigates fundamental properties of redoxmagnetohydrodynamics (redox-MHD) such that it might someday be used to fine-tune
microfluidic pumping and stirring for LOAC applications. MHD offers some unique capabilities
to control local fluid motion that other micropumps cannot.1,2 As illustrated in Figure 1a and 1b,
MHD utilizes a convective force, FB, driven by a magnetic field, B, in the presence of ion
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current, j. This convective force in turn directs fluid flow, based on the cross product
relationship, j B = FB. This project in particular makes use of the MHD theory in conjunction
with a silicon microchip with two sets of gold electrode arrays. Preliminary studies are also
included using a gold macrochip coated with a polymer film that immobilizes redox species to
the surface with minimal loss. It should be noted that programming the potentials at the
electrodes can oxidize and reduce the redox species, producing j in a controlled manner. Several
publications describe this concept.3-6

Flow

(a)

B
(b)

j
Figure 1. MHD Theory. The right hand rule dictates the direction of fluid flow between the
anode and cathode electrode pairs through the array region on the microelectrode chip. The
magnetic field (B) in this diagram points into the page. The ion flux (j) in this diagram points to
the right between anode and cathode pairs. The resuting MHD force and consequent fluid flow
(Flow) thus points upward. Other j vectors are shown in the array diagrams, pointing away from
the anodes and toward the cathodes, resulting in the circular flow.
The polymer studies in this project were conducted with the sulfonated fluoropolymer,
Nafion, and the redox species, hexamine ruthenium (II/III) chloride. Because of its negative
charge, the cations in the Nafion are expected to undergo ion exchange with the
[Ru(NH3)6]3+/2+.7,8 It is proposed that if the redox species can be tethered to the electrode by
exchanging into the polymer film, it will be possible to conduct redox-MHD microfluidics
without the redox species mixing and interfering with the surrounding sample fluid, which has
been a concern about redox-MHD in the past. The ion current will be sustained with the aid of
switching potential waveforms to sequentially activate sets of electrodes in the array, allowing
previously activated sets to recover when the redox species deplete.
When a sufficient potential difference is applied between two electrodes in the presence
of a redox species the anode will cause oxidation (Ru(NH3)2+ = Ru(NH3)3+ + e-) and the cathode
will cause reduction (e- + Ru(NH3)3+ = Ru(NH3)2+), creating a current to flow between the
electrodes. This change in charge must be compensated for somehow. The surrounding
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electrolyte or buffer solution should effectively provide the necessary ions for the ion current in
solution. Other studies from our research laboratory have shown that ion current compensation
from the electrolyte can indeed take place well into the bulk solution between the electrodes.
These arguments and results suggest that it might only be necessary to place redox species at the
electrodes (i.e. tethered) for oxidation and reduction, and therefore the redox species will not
interfere with LOAC samples.
There are several anticipated challenges with a tethered redox species. First, appropriate
redox-species and tethering chemistries must be identified. Second, the thin layer of tethered
redox species will deplete in a short time period (estimated 220 ms for a 500 nm Nafion film).
And third, a switching or potential waveform that allows recovery of redox species is needed.
For these reasons, this project focuses on the initial investigation of tethering redox
species at electrode surfaces (results shown here for the sulfonated fluoropolymer Nafion in
conjunction with the redox species ruthenium hexaamine chloride (Ru(NH3)6Cl3 and
Ru(NH3)6Cl2)).7 Also, it explores potential waveforms that should allow for the recovery of
redox species. Initial studies are shown here with unmodified electrodes and redox species in
solution for the same time period and approximate concentrations as expected for modified
electrodes, varying electrode configuration, timing, potential waveform, and switching.
When studying the efficiency and effectiveness of LOAC devices that use fluid-flow
cells, it is necessary to determine the optimal setup for high speed fluid flow. When the potential
is stepped past the E0 value in such a system, a transient fluid flow occurs immediately after the
step but quickly deteriorates over time according the faradaic current flow (which decreases at
t1/2 as time progresses). It is also important to note that during fluid-flow experiments, the ideal
situation is one in which the fluid movement remains swift for a desired period of time. Due to
the shortness of time that the transient current occurs and complete depletion for a finite number
of redox species at an electrode, we require a means of tuning fluid flow in spite of these two
natural occurrences. Thus, this project proposes a sweep-step function that will utilize two
separate sets of anode-cathode pairs of electrodes. One sweeps from 0.3 V (oxidation) to 0.0 V
(re-establishing a 1:1 mole ratio of oxidized and reduced forms) and then steps to 0.3 V at
different times (at the working electrode side of the pair) and for a number of cycles while the
working electrode of a second set of electrodes is held at the oxidizing potential of 0.3 V.

Experimental Procedures
Chemicals and Materials. All chemicals were reagent grade and used as received. Aqueous
solutions were prepared with high purity deionized water from Ricca Chemical Co. (Arlington,
TX). Polystyrene latex microspheres (10 µm diameter, 2.5 wt % dispersion in water) and
ruthenium (II) hexaamine chloride were purchased from Alfa Aesar (Ward Hill, MA). Potassium
chloride was from VWR (West Chester, PA). Ultra high purity compressed argon gas was
obtained from AirGas. Inc. (Radnor, PA). Potassium ferricyanide (K3Fe(CN)6) was purchased
from EM Science (Gibbstown, NJ) and potassium ferrocyanide trihydrate (K4Fe(CN)6·3H2O)
was purchased from Aldrich Chemical Co. (St. Louis, MO). Nafion perfluorinated ionexchange-resin (5 wt% in a mixture of aliphatic alcohol and 45% H2O) was purchased from
Sigma Aldrich (St. Louis, MO).
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Experimental Setup.
Configuration 1: For gold macroelectrodes. To characterize the gold macroelectrodes, a
3-electrode set up was established using a Ag/AgCl (saturated KCl) reference electrode and Pt
wire counter electrode. The working electrode was a 1.3 cm  1.3 cm gold macroelectrode chip
secured in solution by an alligator clip. The area of the electrode immersed in the electrolyte was
1.3 cm x 0.6 cm. A solution of 0.1 M Ru(NH3)6Cl3 (redox species) in a supporting electrolyte of
0.1 M KCl was freshly prepared prior to all experiments. A supporting electrolyte was used to
minimize the influence of ion migration on the measured faradaic current, it is not electroactive
in the potential range of interest, and it reduces the resistance to the point where electric fields in
bulk solution are small. The CHI 760B potentiostat was used throughout these studies (CH
Instruments, Austin, TX) to perform cyclic voltammetry (CV) and chronoamperometry (CA). All
macroelectrodes were stored, covered, at room temperature prior to experimentation.
Using a Nafion perfluorinated ion-exchange resin, 5 wt% in a mixture of aliphatic
alcohols and 45% H2O (Sigma Aldrich, St. Louis, MO), gold macrochips (1.3 cm  1.3 cm) were
spin coated until completely covered by polymer. In order to ensure a uniform coating, the chip
was covered with Nafion solution completely before the spin coating cycle was initiated.
Macrochips were spin coated at 5 different RPM: 1000, 2500, 3500, 4000, and 6000. Thus, the
macrochips with the thinnest coating of Nafion were those spun at the fastest RPM, 6000.
Approximate thicknesses were measured with a Dektak 3030 and are reported in Table 1. The
Nafion-coated macroelectrodes were cured for one hour at 80°C and allowed to sit in air,
covered, at room temperature for two days before experiments.
Nafion Thickness on Macroelectrodes
Speed of Spin Coating / RPM
Approximate Thickness / nm
1000
557
3500
371
4000
288
6000
183

Table 1. The measured
thicknesses of the Nafion
polymer on the gold
macroelectrodes obtained
with a Dektak 3030.

Configuration 2: For microelectrode array device. See Figure 2 for a schematic of the
setup with the microelectrode array device. Figure 2a is a photograph of the 20-electrode
microchip array device. Prior to MHD experiments, each of the 20 individually addressable
electrodes were checked by characterization in a solution of 0.1 M KCl, 0.1 M K4Fe(CN)6, and
0.1 M K3Fe(CN)6. The characterization experiments utilized a 3-electrode setup was used with a
gold pseudoreference separate from the array, and a counter electrode which was also separate
from the array. Figure 3 shows an overlay of CV responses from one such characterization
(Chip number CN13). For MHD experiments, a two-electrode configuration was used with the
working electrode on one side of the array and the reference and counter leads shorted together
on the opposite array. A CHI 1030A multipotentiostat was used to apply the potential
waveforms throughout MHD experiments. A 760 µm polydimethylsiloxane (PDMS) gasket was
placed on the microchip to hold the solution and define the size of the cell (14.0 mm x 6.0 mm).
The experimental setup is depicted in Figure 2b.
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Figure 2. Schematic of experimental setup for microchip array redox-MHD experiments.
(a) Photograph of microchip array device CN4. The dashed line traces the boundaries of the
cutout in the PDMS gasket that contains solution (defining cell sidewalls). The magnet is not
shown. (b) Photograph of experimental setup. The PDMS gasket used to define the
experimental cell was 760 µm in height, with an inner region cut out (14.0 mm x 6.0 mm). The
NdFeB permanent magnet exhibited an average magnetic field of 0.34 T, and was 1.5 inches in
diameter and 0.5 inches in height.
Sweep-Step Redox-MHD studies. A CH Instruments 1030A multipotentiostat was used
in the redox-MHD sweep-step studies. Working electrode 1 was swept from 0.3 V to 0 V at 1.36
V/s or 0.45 V/s and then held 0.3 V for 0.220 s. This sequence was repeated for 6 cycles.
Working electrode 2 was held at a potential of 0.3 V for the entirety of the two-working
electrode experiments. The counter and reference electrodes were shorted together opposite the
working electrode, on the array region. The NdFeB permanent magnet used in these studies was
1.5” in diameter, 0.5” in height, was purchased from Amazing Magnets (Irvine, CA), and
generates field of 0.34 T, which was measured with a DC Magnetometer. A Nikon Eclipse
ME600P microscope was interfaced to a Sony Handycam digital camera (model no. HDRXR500V; 30 frames per second with 1920 x 1080 pixels per frame) to record solution
movement. Polystyrene latex microspheres (10-µm diameter) were used to visualize solution
movement. A fresh redox species-bead mixture (0.04 vol of 2.5% bead solution : 1 vol redox
solution) was used for each experiment. Bead speeds were tracked using particle imaging
velocimetry (PIV) software (DynamicStudio v.3.00 software, Dantec Dynamics). The PIV
software is able to take several sequential frames of video and create an average image
(eliminating background noise) on which the speeds of moving beads are averaged and plotted.
Video MPG files were converted to single images with 1 step (30 Hz) between each image. The
images generated were then imported into the Dantec software and processed via the average
correlation method. The speeds in Table 2 were obtained as an average of three separate
experimental trials. Data was taken from the region on the array only between the active set(s) of
working electrodes (see designated electrodes in Figures 6 and 8). Speeds occurred at 300 µm
above the floor of the cell. The speeds reported for the sweep segments were taken as an average
over the entire sweep.
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Current / A

Figure 3. Cyclic Voltammograms of the
Characterization of Array Chip
Characterization of Microchip Array
6
Device CN13 in redox solution of 0.1 M
4
K4Fe(CN)6 and K3Fe(CN)6 in 0.1 M KCl
showing that the device is functional.
2
This figure depicts the peak cathodic and
0
anodic currents that occur at each of 18
individually addressable electrodes in the
‐2
potential window 0.3 V to -0.3 V at 0.05
‐4
V/s, sweeping toward the negative
potential. On the forward sweep (ipf) the
‐6
3+
Ru(NH3)6Cl
is reduced. On the reverse
‐8
peak (ipr) Ru(NH3)6Cl2+ is oxidized.
0.4
0.2
0.0
‐0.2
‐0.4
Cathodic and anodic peaks behave
Potential
/
V
similarly for electrodes 2 through 19 on the
microelectrode array chip (CN13). E° ≈ 0.0 V vs. on-chip gold pseudo-reference electrode. The
counter electrode was on-chip but also separate from the array.

Results and Discussion
With experimental configuration 1 (for gold macroelectrodes) and subsequent
experiments, the electrochemistry for each of five different Nafion polymer thicknesses was
compared using redox species “loading” experiments. Results showed that the thicker films
produced more reproducible interactions with [Ru(NH3)6]3+/2+ solution. Table 1 shows the five
speeds at which Nafion polymer was spin coated in addition to corresponding measured
thicknesses. Figure 4 illustrates one such “loading” experiment using a gold macrochip that was
coated with Nafion at 2500 RPM (Nafion thickness at this speed was not measured). The
overlay of CV responses in Figure 4 shows the behavior of a Nafion film in three sequential
experiments: (1) the expected background current in 0.1 M KCl electrolyte alone before loading,
(2) diffusion-limited current from redox species in solution during loading, and (3) expected shift
in E1/2 due to stabilization of oxidized form loaded in negatively-charged Nafion. Because of
this shift, we see that there are electrostatic interactions between the Nafion polymer and the
postively charged redox species, Ru(NH3)63+.
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Potential / V
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Figure 4. Nafion-Coated Gold Macroelectrode
studies. This overlay of CV responses shows the
expected behavior of a Nafion film in three
sequential experiments.
As can be seen in Figure 4, the 0.1 M KCl (the supporting electrolyte in the Ru(NH3)6Cl3
solution) is negligible. There is a peak that occurs from approximately -0.3 V to -0.4 V, but this
is due to the reduction of oxygen in solution. Preliminary studies with the redox-polymer
combination shown here indicate that the combination does exhibit tethering to the electrode
surface, thus it is promising for decreasing interference in redox-MHD future studies. More
work needs to be done in determining the best redox-modfied electrodes suitable for redox-MHD
microfluidics.
These polymer studies, however, segued to the investigation of tuning fluid flow and
redox species replenishment at the electrode array region, again using the array chip depicted in
Figure 2a in the experimental setup depicted in Figure 2b. To this end, a series of studies were
performed in solution containing redox species using different potential waveforms. Two
waveform combinations were utilized, one for short sweep-step studies (Figure 5) and another
for long sweep-step studies (Figure 7). Images obtained using PIV analysis of videos (Figures 6
and 8) allowed for the comparison of bead speeds for control experiments and for experiments
utilizing one and two pairs of active electrodes, separately.
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Figure 5. Waveform Diagram
for Short Sweep-Step Studies.
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(a) Short Sweep‐Step Studies
Controls

Two Electrode Pairs

1A
W1: Step
W2: Off

3A
W1: Step
W2: Step
W1

W1

2A
W1: Sweep
W2: Off

W1

W1

ctr/ref

ctr/ref

ctr/ref

ctr/ref

4A
W1: Sweep
W2: Step

W1

ctr/ref

W2

ctr/ref

W1

ctr/ref

W2

ctr/ref

W1

ctr/ref

W2

ctr/ref

W1

ctr/ref

W2

ctr/ref

Figure 6. PIV Analyses for Short Sweep-Step Studies. During these experiments, the
sweep across potential window 0.3 V to 0.0 V (towards more negative potentials) was
programmed to last 0.220 s at 1.36 V/s for 6 sequential cycles. The large dark arrows were
overlayed to represent the net fluid flow in the region between active electrodes. Speeds
(Table 2) from greatest to least were measured: 3A>1A, 4A>2A.
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Figure 7. Waveform Diagram for
Long Sweep-Step Studies.
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(b) Long Sweep‐Step Studies
Controls

1B
W1:

W1

W1

2B
W1:

W1

W1

Two Electrode Pairs

ctr/ref

3B
W1:

ctr/ref

ctr/ref

ctr/ref

4B
W1:

W1

ctr/ref

W2

ctr/ref

W1

ctr/ref

W2

ctr/ref

W1

ctr/ref

W2

ctr/ref

W1

ctr/ref

W2

ctr/ref

Figure 8. Long Sweep-Step Studies. The working electrode is opposite a counter electrode
shorted to the reference electrode, all on the array region. During these experiments, the sweep
across potential window 0.3 V to 0.0 V (towards more negative potentials) was programmed to
last 0.660 s at 0.45 V/s for 6 sequential cycles. The large dark arrows were overlayed to
represent the region between active electrodes. Speeds (Table 2) from greatest to least were
measured: 3B>1B, 4B>2B.
PIV analysis of the control experiments, which employed only one working electrode
pair (with the counter electrode and reference electrode shorted together on the opposite array as
indicated) are shown in Figures 6 and 8 (1A, 2A, 1B, and 2B). Speeds are reported in Table 2.
The average bead speed was measured from the region of the array only between active
electrodes and at a height of 300 µm from the floor of the cell. During the step part of the cycle
(1A and 1B), fluid flow occurs between active electrodes in a fairly flat flow profile. For the
sweep part of the cycle (2A and 2B), the beads slow to a stop when going from +0.3 V to 0.0 V.
This was expected because the current is lower during the slower sweep. Then, at 0.0 V, a 1:1
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mole ratio of oxidized-to-reduced forms is produced (E = E°) and that is the starting composition
of the solution, thus no net current is generated. Without any current, |j| = 0 and therefore |FB| =
0 and velocity of the fluid is zero.
In experiments utilizing two sets of electrode pairs (3A and 3B), the combined step
produces twice the fluid speed of that for a single set of paired electrodes in the control
experiments. This was expected to occur with twice the active electrodes and twice the current
and with reinforcing flow enhancement. When the W1 electrode set begins its sweep (4A and
4B), the fluid slows to half the speed but continues to flow, because the W2 set of electrodes
continues to produce a current at the 0.3 V potential step, as expected.
Bead Speed During Sweep-Step Studies
Experiment
Speed* / µm·s-1
1A
113.1 ± 19.8
2A
41.3 ± 20.0
3A
232.3 ± 19.9
4A
105.3 ± 21.5
1B
120.6 ± 1.6
2B
14.3 ± 7.1
3B
234.0 ± 18.7
4B
108.8 ± 20.8

Table 2. Bead Speeds for Sweep-Step
Studies (corresponding to experiments
labeled in Figure 6 and 8). The bead speeds
occurred as predicted. Fluid flow was greater
during sweep-step experiments with the
second working electrode held at a potential
than during sweep-step experiments with a
second electrode at open circuit. *Speeds are
averages calculated from three experimental
trials, each from Cycle 1.

Thus, it is observed that fluid continues to flow while alternating electrodes are swept to
recover redox species. In addition to increasing the time that the species has to replenish, a
longer sweep time allows more electrode sets to be included with sweep-step functions that are
out of phase with each other to ensure continuous fluid flow over long times. When future
studies include more functions out of phase with one another, different instrumentation must be
used. A diagram of the ideal waveform sequence has been drawn in Figure 9. Again, this setup
will allow electrodes the be stepped while others are sweeping to allow for continuous
replenishment of species.

Figure 9. Waveform diagram intended for future studies with a different instrument.
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Conclusions
The sweep-step studies investigated here show that fluid flow is increased by twofold as
the number of electrode pairs is doubled. This suggests that the maximum velocity can be tuned
to a specific application by increasing or decreasing the number of electrode pairs that are
activated simultaneously. The current during a sweep decreases with time, and likewise beads
slow to a stop as the sweep progresses in both the short and long sweep studies. Thus, the
working electrodes that are sweeping decrease their contribution to the overall fluid flow. As
long as other electrode pairs are activated with a step, fluid continues to flow, but at a lower
velocity.
If new electrode pairs are stepped to oxidizing potentials only when old electrode pairs
begin their sweep-recovery cycle, then the fluid should achieve a fairly constant velocity with
small pulses at the switching times. However, this kind of switching will require modification
and reprogramming of existing instrumentation. In the future, we hope to be able to create
waveforms such as the one pictured in Figure 9, where cycles are performed on multiple pairs of
electrodes, out of phase with one another, allowing for continued pumping of fluid at some
electrodes while replenishment of redox species occurs at others. The cycles will be repeated
such that fluid flow is sustained over long periods of time. Also in the future, work needs to be
done to tether redox species to electrodes. There was not enough time to investigate the
Nafion/Ru(NH3)63+/2+ system thoroughly. Many other possible systems are reported in the
literature. However, the most optimized conditions will be those where redox species are
covalently attached to avoid loss into surrounding fluid, films are as thin as possible to maximize
electron transfer and diffusion rates (e.g. monolayer), and redox concentrations are high to
minimize frequency of recovery cycles.
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Chemical Synthesis of PdxFey-Pt Nanoparticles as Electrocatalysts
Jonathan Janzen, Northeastern State University
Tahlequah, Oklahoma

Abstract
Platinum (Pt) catalysts used in fuel cells are in need of much improvement,
especially regarding the oxidation reduction reaction (ORR) on the cathode side of the fuel
cell. An approach designed to reduce the amount of Pt used and enhance the catalytic
ability of the catalysts is described, using a core-shell structure with a palladium-iron alloy
as a core and Pt as the shell. Nanoparticles made of mainly Pd with trace amount of Fe
were synthesized using combination of thermal decomposition and reduction in the
presence of different capping ligands. The initial attempt to make core-shell structures is
unsuccessful due to the self-nucleation of Pt.

Introduction
The fuel cell has become the object of much interest due to its ability to convert chemical
energy directly into electricity. In the fuel cell, fuel is separated from oxygen by an electrolyte
membrane. At the anode of the fuel cell, fuel is oxidized as it comes in contact with a catalyst
(H2 2H+ + 2e-). The proton travels across the electrolyte membrane while the electrons travel
through an external circuit. At the cathode side, the oxygen reduction reaction (ORR) takes
place. Oxygen reacts with the electrons and protons, forming water (½O2 + 2e- + 2H+ H2O).
The catalysts for these reactions are generally Platinum (Pt), Pt-based alloys, or carbonsupported catalysts (Pt/C). The catalyst at the anode can have low Pt amounts without
performance loss1; however, slower kinetics at the cathode requires the use of much more
platinum2. This is an issue because of the rarity and the cost of Pt. The problem is that OH tends
to adsorb strongly to the catalyst, blocking the oxygen from reaching it3.
There are several ways to overcome this problem. The surface of a catalyst is what
catalyzes a reaction, and the different facets of a crystal catalyst have different catalytic abilities.
The ORR of a Pt octahedron enclosed by {111} is higher than cube enclosed by {100}3,4,5. The
reason is the OH adsorption on the crystal surface on the {111} plane is less than on the {100}
plane, allowing more oxygen to access the surface of the catalyst3. Also, alloying Pt with 3dtransition metals (e.g. Fe, Ni, or Co) amplifies catalytic ability due to electron coupling2,5. Noble
metals, such as gold, silver and palladium, can enhance the ORR activity by balancing the
strength of adsorption of O and OH. A Pt/Pd alloy is expected to have a very high ORR activity6.
To reduce the amount of Pt used, a core-shell structure can be a potential solution, where only
the surface of the nanocrystal consists of Pt. In this work, attempts were made to synthesize core
materials made of PdxFey, following by addition of Pt to the core.

Experimental Sections
Chemicals. Palladium (II) acetylacetonate (Pd(acac)2, Pd 34.7%), platinum (II) acetylacetonate
(Pt(acac)2 Pt 48.0%), potassium tetrachloroplatinate (II) (K2PtCl4, 99.9%, Pt 46.0%), iron (II)
chloride tetrahydrate (FeCl2·4H2O, 99%), iron (II) stearate (Fe(St)2, Fe 9%), stearic acid (HSt,
90%), tetramethylammonium hydroxide (TMAOH, 25% w/w in methanol), iron (III) chloride
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hexahydrate (FeCl3·6H2O, 97-102%), oleic acid (OA, 90%), 1-octadecene (ODE, 90%), and iron
pentacarbonyl (Fe(CO)5 ,99.99%) were purchased from Alfa Aesar. Iron (III) acetylacetonate
(Fe(acac)3, 99+%) and tungsten hexacarbonyl (W(CO)6, 99%) were purchased from Acros
Organics. Oleylamine (OLA, 70%) was purchased from Aldrich. Tri-n-octylphosphine (TOP,
90%) was purchased from TCI America. All chemicals were used as received without further
purification.
Synthesis Methods.
1. Synthesis of Iron (III) stearate. In a beaker, 5.0 mmol FeCl3·6H2O was added to 6.3 mL of
methanol and stirred until dissolved. Then 15.0 mmol of HSt was added to the solution and
methanol was added for a total of about 30 mL of methanol. The solution was then heated to
boiling and all of the HSt was dissolved. Afterward, 15.0 mmol of TMAOH was added by slow
squirting, and dark, red-brown clumps formed. The solution was kept at 30°C for 30 minutes to
allow the reaction to complete. The gummy product was washed with boiling methanol in a
Buchner funnel. The product was analyzed using an FT-IR and was washed until the peak at
~1740 cm-1 from the carbonyl in HSt was no longer visible.
2. Synthesis of sample 1. Into a three-neck flask, 0.05 mmol of FeCl2·4H2O and 0.05 mmol of
Pd(acac)2 were loaded with 6.0 mL of OLA. The flask was degassed to remove oxygen using a
flow of argon for 10 minutes at room temperature (RT), and it was stirred vigorously for the
remainder of the experiment. The temperature was then set to 130 °C. In a separate vial, 0.05 g
of W(CO)6 (~1.4 mmol) was added to 2.0 mL of OA and 2.0 mL of OLA and degassed under
argon. Using heating, shaking and ultrasonication, the W(CO)6 was dissolved in the vial forming
a bright lime colored solution. When the three-neck flask reached 130 °C, the solution in the vial
was injected into the flask via a glass syringe. The solution in the three-neck flask was then set
to 240 °C and allowed to react for 20 minutes. The flask was removed from heat and allowed to
cool to RT. The product was then washed twice using methanol, centrifuging at 4,000 RPM, and
removing the supernatant. It was then washed four more times in a similar way using a small
amount of toluene with the methanol.
3. Synthesis of sample 2. For this reaction, 0.05 mmol of Fe(St)2 was used as the iron precursor
instead of FeCl2·4H2O, and the reaction at 240 °C went for 45 minutes. All other experimental
conditions remained the same as the synthesis for Sample 1.
4. Synthesis of sample 3. For this reaction, 0.05 mmol of Fe(acac)3 was used as the iron
precursor. All other experimental conditions remained the same as the synthesis for Sample 2.
5. Synthesis of sample 4. For this reaction, 0.05 mmol of synthesized Fe(St)3 was used as the
iron precursor. All other experimental conditions remained the same as the synthesis for Sample
2.
6. Synthesis of sample 5. In a three-neck flask, 0.05 mmol Pd(acac)2 was added along with 2.0
mL of OA, 2.0 mL of OLA, and 4.0 mL of ODE. It was degassed under a flow of argon for 10
minutes. Then 1.0 mL of TOP was injected and the flask was degassed for 30 minutes.
Following this, 0.4 mmol of Fe(CO)5 in 1.0 mL of ODE was injected into the flask, and it was
degassed for 30 minutes. The flask was set to 300 °C and reacted at that temperature for 30
minutes. It was then removed from heat and cooled to RT. The product was washed in a similar
manner as described in the synthesis of Sample 1.
7. Addition of Pt to sample 5. As-synthesized sample 5 was put in a three-neck flask with 4.0
mL of OLA and 4.0 mL of ODE. Then 0.05 mmol of K2PtCl4 was added. The flask was
degassed under argon at RT for 30 minutes, then reacted at 100 °C for two hours. The reddish Pt
precursor was still visible, so the flask temperature was increased to 200 °C and reacted for 90
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minutes. As an alternative method, K2PtCl4 was added to 4.0 mL of OLA in a three-neck flask
and stirred under argon at RT. Then it was slowly heated to 75 °C to attempt to dissolve it under
vigorous stirring, and cooled to RT. Sample 5 was added to 4.0 mL of ODE and injected into the
flask. It was subsequently raised to 160 °C for 1 hour. It was then washed in a similar manner as
described in the synthesis for Sample 1, except acetone was used instead of methanol.
Characterization Method. X-ray diffraction (XRD) patterns were collected using a Rigaku
Miniflex II X-ray diffractometer equipped with a Cu Kα radiation source (λ = 1.5406 Å)
operating at 30 kV/15 mA. Transmission electron microscope (TEM) images were taken on a
Fei Titan 80-300 microscope with an accelerating voltage of 300 kV. Infrared spectra were
obtained using a Bruker Tensor 27 FT-IR spectrometer.

Results and Discussion
The nanoparticles made of Pd and Fe were synthesized using various iron precursors in
an organic solution of OLA and OA. Both can serve as capping ligands for nanocrystals, and
OLA also serves as a reducing agent5. Figure 1 shows the TEM images of the nanocrystals
prepared in samples 1-4. The nanoparticles noticeably aggregated in a toluene solution and they
were not very dispersed in the TEM images.

Figure 1. TEM images of nanocrystals made of Pd and Fe as synthsized from different iron
precursors: (A) iron (II) chloride tetrahydrate, (B) iron (II) stearate, (C) iron (III) acetylacetonate,
and (D) iron (III) stearate.
Figure 2 shows the XRD pattern of samples 1-4. The first two samples look virtually the
same, exhibiting peaks that are quite consistent with face-centered cubic (fcc) crystal structure,
similar to Pd. The slight shift of the peak position is attributed to the composition of Fe (4%) in
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the nanoparticles. The black vertical bars represent the relative position and peaks of that alloy.
Samples 3 and 4 show a few other peaks that are not consistent with a Pd/Fe alloy. The peak at
23 degrees is indicative of an iron oxide, hematite (Fe2O3). The peaks around 30, 54, and 63
degrees are from other type of iron oxide, magnetite (Fe3O4). This result suggested that there are
iron oxides present in the samples 3 and 4 in addition to the Pd/Fe alloy.

Figure 2. XRD patterns of palladium-iron nanoparticles prepared from different precursors: A)
iron (II) chloride, B) iron (II) stearate, C) iron (III) acetylacetonate, and D) iron (III) stearate.
The black vertical lines at the bottom show the relative standard peaks of Pd0.96Fe0.04.

Figure 3. IR spectra of the ligands on the four samples compared with oleic acid (OA) and
oleylamine (OLA). Samples were prepared using various iron precursors, A) iron (II) chloride,
B) iron (II) stearate, C) iron (III) acetylacetonate, and D) iron (III) stearate. The chart on the
right shows what functional groups are responsible for the different peaks.
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Two possible capping agents were used in the synthesis of these nanoparticles. To
determine whether OLA and/or OA were the actual capping ligand, the samples were analyzed
using FT-IR. Figure 3 shows the IR spectra of samples 1 through 4, along with OLA and OA as
control. The peak assignments were listed in Table 1. The peaks at ~2853 and ~2922 cm-1 are
due to the symmetric and asymmetric CH2 stretching modes7,8. The peak at 1710 cm-1 for the OA
is from the C=O stretching8. The peak at 1710 cm-1 is missing in the samples, while the peaks at
~1651 and ~1384 cm-1 are present in the samples. Both of these two peaks arise from the
asymmetric and symmetric vibration of the metal carboxylate7 which is typically in the range of
1650-1510 cm-1 and 1400-1280 cm-1, respectively9. The peak at ~1460 cm-1 may also be due to
the symmetric stretching of the carboxylate group8. This result implies that the nanoparticles in
all samples were capped by OA. The peak at 3320 cm-1 for OLA is from –NH stretching which
is also disappeared in all the samples possibly due to the amine group on the OLA bound to the
surface of nanoparticles.
Table 1. IR peak assignment
Peak (cm-1)
3320
2922
1710
1651
1460
1384

Assignment
NH stretch
CH2 asymmetric stretch
CH2 symmetric stretch
C=O metal asymmetric stretch
COO- symmetric stretch
COO- metal symmetric stretch

The Pd/Fe nanoparticles were also synthesized using TOP as capping ligand. These
nanoparticles were very uniform spheres which were used for Pt coating. The reactions were
performed at high temperature and low temperature. Figure 4 shows the typical TEM images of
the products. At high temperature, the reduction was very fast. As a result, the reduced Pt atoms
were self-nucleated and formed large agglomerates. At low temperature, the reduction slowed
down and fewer agglomerates were found in the production. However, in both cases, no Pt shell
was deposited on the core particles. This is possibly due to two main reasons: 1) the hinderance
of the capping ligand on the nanoparticles blocking the Pt atom diffusion onto their surfaces, and
2) the fast reduction kinetics promoting the self-nucleation of the Pt nanoparticles.

Figure 4. TEM images of Pd/Fe nanoparticles with the addition of Pt at two different
conditions: (A) high temperature and (B) low temperature.
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Conclusion
Nanoparticles made of Pd and Fe were synthesized in solution phase reaction with
different capping ligands. The crystal structures were characterized by XRD. The products were
dominated by Pd component. Depending on the types of Fe precursors, the final products may
contain iron oxide impurities. The initial attempt to make core-shell structures is unsuccessful
due to the self-nucleation of Pt. Future work includes optimization of the core morphology and
composition, as well as control of the reaction kinetics for the Pt shell formation.
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Digestive Enzyme Analysis of Rheb (Ras homolog enriched brain)
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Little Rock, Arkansas

Abstract
Ras homolog enriched brain [Homo sapiens] is a gene consisting of 183 amino acids
and a molecular weight of 20.7 kDa. It is a member of the GTPase superfamily and it
encodes proteins that are bound to lipids in the cell membrane. Some of the major
functions of this protein are cell proliferation, cell differentiation and regulation of growth
due to its interaction with mTOR/S6K1/4E-BP1 signaling transduction pathway. The
protein has GTPase capabilities and switches between a GDP-form and a GTP-form, which
is made possible through phosphorylation, dephosphorylation, and farnesylation ("Rheb
ras homolog," 2011). Protein farnesylation plays an essential role in the membrane and the
interaction between most eukaryotic proteins. In addition, it is catalyzed by the enzyme
farnesyltransferase (FTIs). Current research has brought attention to the biological affects
farnesylation may have on cancer cells, actin cytoskeleton, and cell morphology (F., & CL,
2001). Proteolytic digestions with chymotrypsin and trypsin were used on Rheb-His6 and
the number of fragmentations produced was compared.

Introduction
Rheb
Rheb binds and activates mTORC1, a metabolic regulator that is vital to cancer cells.
Studies have shown that Rheb assists in different stages of cancer development through various
tumor-induced mechanisms. These mechanisms may be contributed to late prognosis of patients
with cancer overexpressing Rheb. However, there has not been enough sufficient research done
to link Rheb with cancer pathogenesis (Lu, 2010).
mTOR/S6K1/4E-BP1
The signaling protein TOR (target of rapamycin; other common names in mammals are
FRAP, RAFT, or RAPT) is classified in the superfamily of phosphatidylinositol kinase-related
kinase and it controls cell growth and the cell cycle from yeast to flies to mammals. The
mammalian target of rapamycin (mTOR) uses nutrients and mitogen signals to control the
growth and division of cells. Rapamycin reduces the cells and mTOR keeps the cell from being
reduced. Therefore, TOR signaling controls cell growth and cell size. Two signaling pathways
that work in conjunction to control mRNA translation also have a dual role as downstream
effectors of mTOR. These effectors are ribosomal protein S6 kinase 1 (S6K1) pathway and the
eukaryotic translation initiation factor 4E (Eif4E)-binding protein 1 (4E-BP1 or PHAS-I)/eIF4E
pathway (Fingar, 2003). Many researchers suggest that S6K1 plays a vital role in the S-phase of
the cell cycle. On the other hand, 4EBP1/eIF4E does not have a critical role in the cell cycle
progression but it is overexpressed in human tumors. S6K1 and eIF4E pathways function
separately to increase cell size along mTOR and it promotes mTOR-dependent cell cycle
progression coupled with cell growth during cell proliferation (Yu, Li, Xu, Li, & Guan, 2005).
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Protein Purification
Protein purification isolates and breaks down large individual proteins into fragments that
can be used to examine protein activity. Proteins can function as enzymes, signals, or receptors.
In addition, they play a role in gene expression. Purification is a process that includes three
stages: fractionation, purification, and polishing. Fractionation is a preparation step and the
beginning of reduction steps. During fractionation, proteins are being separated using a
centrifuge, microfilter system, or lysis buffer. The purification step continues to break down the
protein and eliminates contaminants by using chromatography. The purpose of chromatography
is to separate different cell constituents using chemicals. Polishing removes parts of the protein
that is degrading and allows the protein to be preserved and stored over a period of time (Lohrey,
2010).
Digestive Enzymes
Enzymes are highly energized proteins that catalyze biological systems and determine
chemical changes (Berg, Tymoczko, & Stryer, 2007). They are specific and bind to particular
active sites. These protein molecules are required for the digestion of food, brain stimulation, and
producing cellular energy. Digestive enzymes are found in the gastrointestinal tract and their
purpose is to break down food so nutrients can be extracted and absorbed easily. Also, enzymes
are present in raw foods and they aid in starting the digestion process, which lowers the amount
of digestive enzymes secreted. When cooking at moderate to high temperatures, food enzymes
get destroyed. However, if the body has to constantly rely on its own enzymes; more stress will
be put on the biological system (“Digestive Enzymes”).
There are numerous proteolytic enzymes that help break down proteins in the digestive
system. Chymotrypsin is an example of a digestive enzyme that slices peptide bonds specifically
on the carboxyl-terminal (C-terminal) side of the hydrophobic and aromatic amino acids, such as
phenylalanine and methionine. In addition, chymotrypsin is an example of using covalent
catalysis because the nucelophile becomes covalently attached to the substrates’ unreactive
carbonyl carbon. Trypsin is another amino acid that slices peptides on the C-terminal side of
lysine and arginine amino acid deposits (Worthington, 2009).
Digestive enzymes are important because they work together as catalysts to aid in
absorption and digestion. Enzymes are essential to the body because without them food would
not be broken down and nutrients could not get absorbed and transported into the blood stream.

Experimental Procedures
Test Expression and Protein Purification
First, two 1L and one 250ml flasks of LB media were made and autoclaved for an hour
[1L water: 25.0g LB media; 250ml water: 6.3g LB media ]. Then, the flasks cooled down for 30
minutes. Next, 250µl of ampicillin was pipetted into the 250ml flask and 1ml of the Rheb-His6
protein was pipetted into the same flask. After, the flask was placed on a shaker (370C)
overnight. The next day the O.D. was measured and the formula [
∗ . . 0.05 was
used to calculate how much protein should be used to inoculate the fresh LB media. Then, 1ml
of ampicillin was pipetted into both 1L flasks. Next, both flasks were inoculated with the
calculated amount of proteins and then placed on a shaker until the cells reached an O.D.
between 0.6-0.8. After, a 120µl aliquot (add 20µl 8M urea and 40µl 4xSDS Loading Dye) was
taken and labeled (Rui). Then, 400ml of the protein was taken from one of the 1L flasks and
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placed in an eppendorf tube. The tube was balanced and spun on maximum in an eppendorf
microfuge for 15 minutes. Next, the supernatant was poured into the biohazard trash bin with
only the pellet left in the eppendorf tube. The pellet was resuspended in urea (120µl) and 40µl
of loading dye was added. Then, the eppendorf tube was placed in the VWR incubator for 2
minutes at 900C. Next, the eppendorf tube was labeled (Ri ) and stored at -800C. Later, 200µl of
IPTG was placed in both 1L flasks and incubated at room temperature for 4-5 hours. Next, the
cells from the two 1L flasks were poured into 6 centrifuge bottles and balanced. Then, the cells
were centrifuged (6500rpm, 15mins, 40C). After, the supernatant was discarded and the pellets
were left in the bottles. Next, the cells were resuspended in Binding Buffer for PBS-Ni2+ Affinity Purification. 40ml of the buffer was poured into a beaker and 5ml of the buffer was
pipetted into each of the 6 bottles. Then, the cells were poured into a 50ml tube, balanced, and
centrifuged (Jouan centrifuge) for 15 minutes. After, the supernatant was discarded and the
pellets were placed in a -800C freezer (not necessary if continuing the procedure). Later, fresh
lysis buffer was made and placed on ice, while the cells unthawed on top of the ice for an hour.
Next, the cells were resuspended in fresh lysis buffer. Then, the cells were sonicated 5 times for
20 seconds with 1 minute intervals while still in ice. After, the lysate was incubated on ice for
30 minutes. During the incubation period, the FPLC was cleaned. Next, a small scoop of
DNAse was added to the lysate and incubated for 15 minutes at room temperature. Then, the
lysate was poured into a tube, balanced, and centrifuged (19500rpm, 15 minutes, 40C). After, the
supernatant and pellet were filtered. Next, an aliquot of the supernatant and the pellet was taken
[small scoop of supernatant (RL=Rheb lysate); pellet+60µl of 8M urea (Rp=Rheb pellet); added
40µl of 4 x Loading Dye to each]. After, the lysate ran over Ni2+-Affinity Column on the FPLC.
Next, an aliquot of the flow through (RFT) and Pool Fractions (Rpool) were taken. The aliquots
were placed in a freezer at -800C and the sample was placed in a tube and refrigerated. Later, a
15% SDS gel was loaded and ran (200V, 65mA, 60mins). Then, a dialysis of pure Rheb was
done in 1xPBS-Buffer+0.010M MgCl2 x 6 H20 overnight at 40C (MWCO Dialysis Bag=60008000 kDa). Later, the protein content was determined. Then, the protein was concentrated and
an aliquot was taken.
Digestive Enzyme Assay
First, 2mg/ml of chymotrypsin was made. Then, 7 eppendorf tubes were labeled (0 minutes,
1 minute, 5 minutes, 10 minutes, 20 minutes, 30 minutes., 60 minutes). Next, chymotrypsin to
Rheb-His6 concentrations (1:10 ratio) was calculated for incubation. Then, an aliquot of Rheb
and chymotrypsin (30µl of Rheb and 30µl of chymotrypsin; 10µl of 4 x loading dye in each) was
taken and frozen immediately. After, 500µl of Rheb and 970µl of chymotrypsin were incubated
at room temperature in a water bath for 5 minutes. Next, the calculated amount of chymotrypsin
to Rheb sample was made and then the extra chymotrypsin was frozen immediately. Then, the
Rheb/Chymotrypsin sample was incubated in time intervals of 0 minutes, 1 minute, 5 minutes,
10 minutes, 20 minutes, 30 minutes, and 60 minutes. After each time interval was reached, 30 µl
of the sample was placed into the desired eppendorf tube. Then, 10 µl of the 4 x loading dye was
added and the eppendorf tube was placed in liquid nitrogen. Lastly, a 15% SDS gel was made
and ran. The process was repeated using trypsin.
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Results and Discussion

Figure 1: Rheb GTPase Cycle in cell-cycle regulation

A

B

Figure 2. Purification of Rheb-His6 protein. A, chromatogram from the purification of Rheb-His6; B, 15%
SDS-GEL analysis of fractions from the purification of Rheb-His6. Lane 1, molecular weight marker (kDa);
lane 2, uninduced Rheb; lane 3, induced Rheb; lane 4, protein pellet; lane 5, supernatant; lane 6, flow-through
fraction; lane 7-10 eluted protein.
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Figure 3. Chymotrypsin. Gel electrophoresis of chymotrypsin assay. Lane 1, molecular weight maker (kDa).
Lane 2, Rheb. Lane 3, Chymotrypsin. Lane 4, 0 minutes. Lane 5, 1 minute. Lane 6, 5 minutes. Lane 7, 10
minutes. Lane 8, 20 minutes. Lane 9, 30 minutes. Lane 10, 60 minutes.

Figure 4. Trypsin. Gel electrophoresis of trypsin assay. Lane 1, molecular weight maker (kDa). Lane 2, Rheb.
Lane 3, Trypsin. Lane 4, 0 minutes. Lane 5, 1 minute. Lane 6, 5 minutes. Lane 7, 10 minutes. Lane 8, 20
minutes. Lane 9, 30 minutes. Lane 10, 60 minutes.

The digestive enzyme assay was repeated three times to gain better results. Of the four
assays, one produced quality results. According to the chymotrypsin SDS-Gel, Rheb was
completely digested at zero minutes. However, the trypsin SDS-GEL showed evidence of some
fragmentation, even though the intensities of the Rheb bands were not significantly different.
Overall, these results show that the ratio of chymotrypsin to Rheb was too low and the
incubation period for the trypsin to Rheb sample should be extended to produce more fragments.
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Conclusion
The objective of this project was completed but more research is needed to understand
the affects chymotrypsin and trypsin has on Rheb. Also, a minor change in the methodology is
suggested to produce better results. However, future research studies will be targeted towards
analyzing protein patterns and protein interactions; labeling small fragments of the protein that
have been cleaved by digestive enzymes; and using fluorescent dye as a control to compare the
number of fragmentations produced by each enzyme.
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Tailoring Polymer-Coated Gold Nanocages for Chemical Sampling in a
Microdialysis Device
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Lawton, Oklahoma

Abstract
Gold (Au) nanocages have extensive biomedical applications. The polymer poly-Nisopropylacrylamide (p-(NIPAAm)) is a thermally responsive polymer that can change its
structural conformations with change in temperature with respect to its low critical
solution temperature (LCST). Gold nanocages with localized surface plasmon resonance
(LSPR) tuned near IR region are coated with p-(NIPAAm) and this polymer controls the
release of samples from nanocages with the temperature change. Besides other biomedical
applications of p-(NIPAAm) coated nanocages such as drug delivery, photoacoustic
imaging, photothermal therapy, and contrast agent, this preliminary study was done to
demonstrate as proof of principle if these nanocages can be used for chemical sampling
through microdialysis device. Microdialysis sampling is a minimally invasive device that
collects samples via diffusion from different tissues and organs with aid of semipermeable
hollow fiber membrane. The analyte diffuse into the semipermeable membrane and
carried out by perfusion fluid for further chemical analysis. The main objective of our
study is to demonstrate if p-(NIPAAm) coated gold nanocages passed in the perfusion fluid
could collect analytes through microdialysis sampling. Our study results showed that p(NIPAAm) coated nanocages can be used for chemical sampling without any damage to
microdialysis probe.

Introduction
Gold (Au) nanoparticles have been the part of intensive biomedical applications such as
chemotherapy, photothermal therapy, and optical imaging.
Gold nanocages are the
nanostructures prepared by galvanic replacement reaction where a gold salt precursor
(chloroauric acid) is titrated into a solution of sacrificial silver (Ag) nanocube suspension.1 The
interior part of Ag nanostructure is oxidized and reduced Au atoms grow on the surface of
nanocubes producing Au nanocages.5 Au nanocages have porous walls and a hollow interior
with unique tunable localized surface plasmon resonance (LSPR) varying the size of nanocages
and their pores. For biomedical applications, LSPR peak of Au nanocages should be tuned to
near infrared region.1 Thermally sensitive polymers poly (N-isopropylacrylamide) (p(NIPAAm)) with low critical solution temperature (LCST) of 32oC are used to coat the Au
nanocages. When temperature is below LCST, the polymer is hydrophilic in nature and when
temperature is above LCST, the polymer becomes hydrophobic.2This polymer is heat-sensitive
and its conformation changes with temperature with respect to its LCST.3 Polymer coated
nanocages at temperature above LCST results in shrinking of hydrodynamic diameter of polymer
leading to exposure of pores of nancoages, and thus releasing samples from the core or
entrapping samples inside the core. Temperature below LCST causes polymer to stretch out and
covers the pores of nanocages and thus restricting the movement of samples through the pores.
This conformational change of polymer controls the release of samples from Au nanocages. So
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we attempt to use polymer coated nanocages as carrier for chemical sampling using
microdialysis device.
Microdialysis sampling is a minimally invasive device that helps to collect samples via
diffusion from different tissues and organs of the body for biochemical studies. It is a simple invivo technique of collecting samples with the aid of probe consisting of semipermeable hollow
fiber membrane with 200-500 μm diameter and 1-30mm length inserted into the different tissues
and organs.4 The analytes diffuse through the semipermeable membrane and they are carried out
through outlet impermeable membrane as dialysate. Detection of dialysate can be quantified in
mathematical expression called extraction effienciency (EE) which is the ratio of the
concentration of analyte extracted from microdialysis sampling (Coutlet) to that of analyte stock
(Cinlet) as expressed in equation 1.6
%

1

Extraction efficiency of chemical sampling depends on the perfusion flow rate,
concentration of perfusion fluid and analyte, diffusion coefficient of analyte, and molecular
weight cut off (MWCO), material, and pore size of membrane. Microdialysis sampling has been
applied in many areas of neuroscience and biotechnology. A microdialysis probe has shown
promising adaptation to diversified applications, and samples analysis that are easily done by
available technologies. So our vision is to use polymer coated nanocages for chemical sampling
using the microdialysis probe as shown in Figure 1. At temperature above LCST of polymer,
polymer coated Au nanocages inside microdialysis membrane can entrap diffused analyte into its
core and entrapped analyte can be further analyzed. The main objective of this study is to
demonstrate if polymer coated nanocages could act as carrier and entrap samples using
microdialysis device.

Figure 1: Schematic illustration of polymer-coated-nanocages for chemical sampling in
microdialysis device.

Experimental Sections
Synthesisof Ag nanocubes: Ethylene glycol (EG), 50 mL was heated to 150oC and
stirred. At 150oC, EG solutions of 0.6 mL of 3mM NaHS, 5 mL of 3 mM HCl, and 12.5 mL of
Polyvinylpyrrolidone (PVP) (0.35 g PVP dissolved in 17.5 mL) were added to the solution.
After 2 mins, 4 mL of silver trifluoroacetate in EG solution (282) mM was added to the reaction
mixture and heated for 35-45 mins at 150oC.
Synthesis of Au nanocages: Deionized water in 100 mL round bottom flask was heated
and stirred for 10 mins. 500 μL of Ag nanocube suspension was added to water. Chloroauric
acid (HAuCl4) solution (1 mM) was titrated to the Ag nanocube solution. The UV-Vis spectrum
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of the sample was taken. NaCl crystals were added to sample until the solution saturated and
stored for an hour. The sample was centrifuged at 14000 rpm for 15 mins and clear solution was
discarded. The sample was redispersed with 1.5 mL water and washed twice. The sample was
resuspended by 0.1 mL water.
Surface coating of Au nanocages by p- (NIPAAm): Thermally responsive polymer p(NIPAAm) (MW~12,000) (10 mL of 0.33 mM) with LCST 32oC was titrated by 5 mL of 1.6 nM
Au nanocages at the rate of 0.2 mL/min. The reaction solution was stirred for 5 days at room
temperature. The polymer coated nanocages was centrifuged at 14000 rpm for 15 mins at 20oC
and supernatant was discarded. The nanocages were washed 4 times and it was resuspended
with 0.6 mL deionized water. For the controlled release of dye, copolymer p-(NIPAAm-coAAm) (poly-N-isopropylacrylamide-co-acrylamide) with LCST 41oC was used for surface
coating of Au nanocages.
Loading of Rhodamine B (RB) dye in copolymer coated Au nanocages: The
suspended copolymer coated Au nanocages (0.6 mL)was mixed with 10 mL of RB dye (~18
mM) and it was vortexed and sonicated for 10 mins. It was placed in oil bath at 50oC overnight.
The solution was placed in ice bath for an hour. It was centrifuged at 14000 rpm for 15 mins at
20oC and supernatant was discarded. The solution was washed until the absorbance of
supernatant at 554 nm was less than 0.05.
RB dye release from copolymer coated Au nanocages: RB dye loaded copolymer
coated nanocages were suspended with 0.6 mL warm water (50oC) and vortexed. It was placed
in water bath at 50oC for 2 mins and immediately placed in ice bath for 5 mins. It was
centrifuged at 14000 rpm for 15 mins at 20oC and UV-Vis spectrum reading of supernatant was
taken. After absorbance reading, supernatant was returned back to the nanocages and again it
was placed in water bath for next time intervals of conventional heating.
Microdialysis Sampling: The microdialysis setup is shown in Figure 1 and 2. Polymer
p-(NIPAAm) coated Au nanocages ranging the concentration from µM to nM were used as
perfusion fluid in the microdialysis sampling. The semipermeable membrane was immersed in
the analyte solution (dyes) and the flow rate of perfusion fluid was adjusted depending on the
experimental setup. The concentration of analyte used was in the range of µM. The
microdialysis probe used was PES (Polyethersulfone) of 100 kDa. Chemical sampling was
carried out in two different conditions: placing microdialysis probe along with analyte in sand
bath (37-40oC) and placing microdialysis setup in warm room (37oC).
Instrumentation: Transmission electron microscope (TEM) images were taken on a FEI
Titan 80-300 microscope with an accelerating voltage of 300 kV. The UV-vis spectra were
obtained using a UV-vis spectrometer (HP 8453A). The hydrodynamic diameter was measured
using a dynamic light scattering (DSL) instrument (Brookhaven ZetaPALS).
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Figure 2: Diagrammatic microdialysis sampling set up

Figure 3: (Left) Microdialysis sampling set up and (Right)Microdialysis probe.

Results and Discussion
Gold nanocages were synthesized by galvanic replacement reaction such that reduced Au
replaces the oxidized Ag atoms. When Ag nanocube suspension is titrated with gold salt
solution precursor (HAuCl4), Ag atoms get oxidized which dealloys the Ag/Au nanostructures
and changes the structural composition of Ag nanocubes into Ag nanocages. With the increase
in titrated volume of HAuCl4 solution into the Ag nanocube suspension, there was a red shifting
of LSPR peak to near IR region and the observation of series of color change from yellow,
orange, maroon, purple, navy blue to fading blue (Figure 4). The LSPR peak of Au nanocages
can be tuned to desired wavelength and for this experimental purpose there was requirement of
LSPR peak to be tuned near IR region (780-800 nm). Most of Au nanocages synthesized had
their LSPR peak wavelength ranging from 775 nm to 805 nm.
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Figure 4: Tuning of LSPR peaks of Au nanocages at different wavelengths: (Left) UV-Vis
spectra of samples prepared by different titrated volumes of HAuCl4 solution were taken. With
the increase of titrated volume of HAuCl4 solution on Ag nanocube suspension, the LSPR peak
wavelength red shifted. (Right) Photograph of the sample solution (going from left to right) with
the increase in titrated volume of HAuCl4 solution on Ag nanocube suspended solution.
Figure 5 shows the TEM image of p-(NIPAAm) coated Au nanocages and the UV-Vis
spectra for both PVP-coated and p-(NIPAAm) coated Au nanocages. The size of the nanocages
is 40±5 nm. There was observation of red-shifting of LSPR peak after replacing PVP polymer
by p-(NIPAAm) on surface of Au nanocages. In order to further confirm the exchange of PVP
polymer by p-(NIPAAm) polymer on the surface of Au nanocages as well as to observe the
change of hydrodynamic diameter of p-(NIPAAm) coated Au nanocages above and below its
LCST (32oC), the DLS experiment was carried out (Figure 6). At two different temperatures, 25
o
C and 37oC, the change of diameter of p-(NIPAAm) coated nanocages was observed unlike
PVP coated nanocages. The PVP coated nanocages exhibited negligible change in diameter with
temperature change whereas, p-(NIPAAm) coating showed significant changes such that above
LCST (37oC) diameter decreased (shrinked) and it reversibly expanded below LCST (25oC) as
shown in Figure 6. At 37 oC, the hydrodynamic diameter of the nanocages was measured to be
105±1 nm and 121±4 nm for PVP-coated nanocages and p-(NIPAAm) coated nanocages,
respectively.

Figure 5: (Left) TEM imageof p-(NIPAAm) coated Au nanocages and (Right) Red-shifting of
LSPR peak with the change of polymer coated on Au nanocages. LSPR peak of PVP nanocages
is at 789 nm and that of p-(NIPAAm) nanocages is at 795 nm.
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Figure 6: Observation of diameter change with change in temperature with respect to LCST of
polymer p-(NIPAAm).
Gold nanocages with LPSR peak at near IR region were coated with thermally responsive
copolymer p-(NIPAAm-co-AAm) having LCST 41oC. The RB dye (~18mM) was loaded on
copolymer coated Au nanocages in order to figure out how the temperature affects the release of
dye from the nanocages and also to check the functionality of nanocages as shown in Figure 7. It
was observed through UV-Vis spectra of supernatant at 554 nm that with the increase in time
intervals of conventional heating beyond LCST of copolymer, there was increase in the amount
of RB dye released from the nanocages. The copolymer has the LCST 41oC so when copolymer
coated nanocages was placed in water bath of 50oC at certain time intervals, copolymer shrinks
as a result of which porous walls of nanocages get exposed and releases dye in supernatant.

Figure 7: Controlled release of RB dye from copolymer coated Au nanocages with LCST
41 C: Absorption spectra of RB dye released at 554 nm were measured for different time
intervals of conventional heating. It demonstrated that the higher time interval of heating of RB
dye loaded nanocages, the more release of dye from nanocages.
o

Microdialysis sampling was carried out using methyl orange dye (MO) and p-(NIPAAm)
nanocages of concentration 16.7 M. The absorbance peak of MO dye is at 465 nm. The
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microdialysis probe was immersed in the analyte MO stock solution. The analyte was placed in
sand bath at temperature 40oC. Flow rate of perfusion fluid is one of the important factor to
affect the extraction efficiency (EE%) of chemical sampling. As shown in Table 1, EE% of
analyte sampling increased with the decrease in the flow rate of perfusion fluid. Maximum EE%
could be achieved using slow perfusion flow rate because it allows more time for diffused
analyte to get entrapped or adsorbed by polymer coated nanocages.
Table 1: Flow rate of perfusion fluid affects the extraction efficiency of microdialysis sampling.
Flow rate
(L/min)

Perfusion
Fluid

Analyte

Inlet
concentration
M

Outlet
concentration
M

(EE)
%

Std.
dev.
%

1

pNIPAAm
nanocages

MO

20.5

4.3

21.1

-

5

pNIPAAm
nanocages

MO

20.3

1.4

6.8

-

Recovery of
Nanocages
%
Not
measured

~100

For the next experimental set-up, 1 L/min perfusion flow rate was used. Microdialysis
sampling was carried out in warm room at 37oC temperature using p-(NIPAAm) coated
nanocages (0.1 nM) and water (control) as perfusion fluid, as shown in Table 2.The EE% of
microdialysis sampling using p-(NIPAAm) nanocages as perfusion fluid was less than using
water (Control). The possible reason might be due to not being able to detect the dye entrapped
inside the nanocages. But the results demonstrated that p-(NIPAAm) nanocages can be used in
microdialysis sampling in order to collect analyte comparing the EE% of chemical sampling
using p-(NIPAAm) coated nanocages versus water. These nanocages can be applied in
microdialysis sampling without probe damage as they are recovered completely through outlet.
Table 2: Comparison of EE% of chemical sampling
Perfusion
Fluid

Analyte

Inlet
concentrationM

Outlet
concentration
M

Extraction
Efficiency
(EE)
%

Standard
Deviation
%

Recovery of
Nanocages
%

pNIPAAmnanocages

MO

16.8

5.6

33.2

0.7

~100

Water

MO

21.9

9.1

41.4

1.3

Not
measured

To determine the non-specific adsorption of dye on the p-(NIPAAm) coated nanocages,
the control experiments were performed at room temperature. The result in Table 3 shows that a
small amount of MO dye was lost when the MO solution was incubated with the p-(NIPAAm)
coated nanocages. This loss of the MO could be attributed to the adsorption of dye by the p(NIPAAm).
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Table 3. Non-specific adsorption of dye on p-(NIPAAm) coated nanocages.
Temperature(oC)
MO stock (μM)
MO in supernatant (μM)
MO loss (μM)
25 (R.T.)
21.6
20.2
1.4

Conclusion
The p-(NIPAAm) coated nanocages can be used for the collection of samples through
microdialysis sampling. There is no damage of microdialysis probe because of these nanocages
are fully recovered through microdialysis probe. The results of this study showed that the
extraction efficiency of analyte using p-(NIPAAm) nanocages as perfusion fluid increased with
the decrease in perfusion flow rate. On the other hand, the extraction efficiency of analyte using
perfusion p-(NIPAAm)nanocages is less compared to water (control). The possible reason might
be due to the dye entrapped inside the nanocages. Further experiments need to be carried out to
quantify the entrapped dye by releasing them from the nanocages. As per our objective, p(NIPAAm) coated nanocages can be used as perfusion fluid to carry out chemical sampling. The
sampling efficiency of microdialysis can be optimized by concentration, porosity, and coating
layer of perfusion nanocages.
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Expanding the Scope of the Catalytic Dynamic Resolution of N-Boc-2Lithiopiperidine
Jin Sun Woo, Mount Holyoke College
South Hadley, Massachusetts

Abstract
The scope of the catalytic dynamic resolution (CDR) of N-Boc-2-lithiopiperidine 1 has been
expanded toward the scaled-up synthesis of (R)-pipecolic acid methyl ester 3.
1. 10 mol % 2, -45 oC, 3 h
2. -78 oC, MeOCOCl
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Introduction
Optically active piperidine derivatives are prevalent in natural products and are used in
thousands of clinical and preclinical trials.1 For example, (-)-swainsonine is a potentially useful
antimetastasis drug for cancer treatment,2 and conhydrine is a poisonous alkaloid in hemlock3
(Figure 1). The pipecolic moiety is a key structure in antamiscomicin B4. The enantioselective
synthesis of piperidine derivatives has been the subject of investigation by many researchers.5
Recently, Beng and Gawley discovered a catalytic dynamic resolution (CDR) of N-Boc-2lithiopiperidine using dilithiated diamino alkoxide ligands (S,S)-2 and (S,R)-2, which afford
either enantiomer of the 2-substituted piperidine in good yields and excellent enantioselectivity6
(Scheme 1). In small scale reactions (<5 mmol), the authors synthesized both enantiomers of the
proline homologue, pipecolic acid as well as the ester and amide derivatives in >97:3 er. In the
wake of the important finding, there is a growing interest in implementing the CDR methodology
as an alternative to a classical resolution, which is still the most practical way to obtain
enantiopure compounds on an industrial scale.
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Figure 1. Piperidine alkaloids.
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Scheme 1. CDR of N-Boc-2-lithiopiperidine 16
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Objective
The goal of this project was to synthesize multigram quantities of enantioenriched
pipecolic acid or its derivatives, for use in the total synthesis of antascomicin B.

Results and Discussion
As the starting material, N-Boc-piperidine was prepared by the reaction of di-tert-butyl
dicarbonate and piperidine in dichloromethane (Scheme 2). 24.30 g of the desired product was
obtained as an oil in 100% yield, data as reported.6
Scheme 2. Synthesis of N-Boc-Piperidine.
N
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Toward the synthesis of (S,R)-2, the (S,R)-dipeptide ester 4 was synthesized by peptide
coupling reaction of (S)-N-Boc-leucine and D-proline methyl ester hydrochloride in the presence
of EDCI and HOBt in chloroform (Scheme 3). 1.26 g (76%) of the dipeptide ester was obtained.
The reduction of the dipeptide ester was followed. 1.15 g of the conjugate acid of crude (S,R)-2
was obtained as viscous oil.
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Scheme 3. Synthesis of the conjugate acid of (S,R)-2.

H

+
N
CO2H
Boc
LiAlH4 / THF
reflux, 16 h
~100%

EDCI (1 equiv), HOBt (1 equiv)
CO2Me CHCl / Et N, rt, 10 h
N
H
N
3
3
N
H·HCl
76%
CO2Me
Boc O
4
H

N
Me

N
OH

The conjugate acid of diastereomeric ligand (S,S)-2 was also synthesized in the same
way, to give 0.56 g (71%) of the product.
R-3 was synthesized by CDR using ligand (S,S)-2 (Scheme 4). After deprotonation of NBoc-piperidine using s-BuLi and TMEDA at –80 oC for 3 h, the addition of 10 mol% of (S,S)-2
and 3 h of equilibration were followed. After cooling to –80 oC, methyl chloroformate was
added. CSP-GC traces showed one peak thus indicating that enantiopure R-3 was obtained.
Scheme 4. Synthesis of R-3 by CDR
1. s-BuLi, 4 equiv TMEDA, -80 oC, 3 h
2. 10 mol % (S,S)-2, -45 oC, 3 h
3. -78 oC, MeOCOCl
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Experimental
N-Boc-Piperidine.
To a 250 mL round bottom flask containing piperidine (9.89 g, 131.5 mmol, 1.0 equiv), di-tertbutyl dicarbonate (28.7 g, 131.5 mmol, 1.0 equiv) in CH2Cl2 (100 mL) was added slowly by
dropping funnel at 0 °C. The mixture was stirred for 3h and washed with saturated NaCl (3 x
50mL) and with H2O (2 x 50 mL). The combined organic layers were dried over MgSO4 and
filtered and evaporated.
Conjugate acid of (S,R)-2.
Step 1. Boc-(L)-leucine (2.12 g, 4.83 mmol, 1.0 equiv) was dissolved in CHCl3 (20 mL) in 100
mL round bottom flask. EDCI (0.95 g, 4.83 mmol, 1.0 equiv) and HOBt (0.73 g, 4.83 mmol, 1.0
equiv) were added. The mixture was stirred for 10 min. D-Pro-OMeHCl (0.80 g, 4.83 mmol,
1.0 equiv) in CHCl3 (10 mL) and Et3N (2 mL) was added to the mixture slowly. The mixture
was stirred at room temperature for 10 h. The solvents were evaporated. Ethylacetate (10 mL)
was added, and the mixture was stirred for 30 min. The suspension was filtered. The filtrate was
washed with10% citric acid (3 x 10 mL) and with 10% NaHCO3 (2 x 10 mL). The organic layer
was dried over MgSO4 and evaporated.
Step 2. A stirred suspension of LiAlH4 (1.4 g, 36.80 mmol, 10.0 equiv) in THF (100 mL) was
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cooled to 0 oC. A solution of the (S,R)-4 (1.26 g, 3.68 mmol, 1.0 equiv) in THF (30 mL) was
added dropwise to the suspension. The mixture was stirred for 10 min at room temperature and
refluxed for 16 h. The mixture was cooled to 0 oC and Et2O (50 mL) was added. The mixture
was carefully quenched by slow addition of 50% NaOH(aq) (100 mL) while stirring until all salts
appeared white. The solvent was decanted, and the white solid was washed with Et2O. The
combined organic layers were dried over MgSO4 and evaporated. The crude was purified by
Kugelrohr distillation.
NMR spectra of (S,R)-2
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NMR spectra of (S,S)-2

Synthesis of R-3.
In an oven-dried, septum-capped 25 mL round bottom flask equipped with a stir bar, N-Bocpiperidine (0.185 g, 1 mmol, 1 equiv) and freshly distilled TMEDA (.15 ml, 4 mmol, 4.0 equiv)
were dissolved in freshly distilled Et2O (10 mL) under argon. The solution was cooled to –80 °C
and s-BuLi (1.2 equiv) was added slowly by means of a syringe over a ten minute period. The
mixture was stirred for 3 h. The conjugate acid of (S,S)-2 (0.022 g, 0.1 mmol, 10 mol%) in Et2O
(10 mL) was treated with freshly titrated s-BuLi (20 mol%). The preformed alkoxide S,S-2 was
added and the flask was quickly transferred to a second thermostatted bath at –45 °C, and
allowed to stir for 3 h. The mixture was cooled to –80 °C and rapidly quenched with methyl
chloroformate (0.23 mL, 3 mmol, 3.0 equiv). After 2 h, MeOH was added and the mixture was
stirred for 5 min. After warming to room temperature, 2 M HCl was added. The layers were
separated and the aqueous layer was extracted with Et2O. The combined organic layers were
dried over MgSO4 and evaporated to obtain the crude product . The er was determined by CSPGC.
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CSP-GC trace of the rac-3 and R-3 of >99:1 er
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Synthesis of JWH-018 Metabolite
Patience Wright, Spring Hill College
Mobile, Alabama

Abstract
Beginning in 2004, herbal mixtures with the name “Spice” or “K2” were sold in
“headshops” and on the internet. These mixtures contain 1-pentyl-3-(1-napthoyl)indole,
also known as JWH-018. Although JWH-018 and delta-9-tetrahydrocannabinol (Δ9-THC)
have different structures, both give cannabis-like effects after consumption. Hallucination,
distorted perception, and tachycardia are common effects of usage. Due to this, the Drug
Enforcement Agency (DEA) is conducting further studies to determine if these mixtures
should be permanently placed on the controlled substances list prohibiting their sale and
consumption. For this project, the authors synthesized a JWH-018 metabolite and
analyzed the products using gas chromatography-mass spectroscopy (GC/MS). The
metabolite was synthesized to mimic the metabolized product found in K2 users’ urine
after its consumption. Hydroxylation on the alkyl chain is the most common metabolite
found in urine; therefore, the authors choose to synthesize it to act as an analytical
standard to compare to urine samples of K2 users. Since the carboxylic acid form is the
second most common metabolite found, future studies will work toward continuing the
synthesis.

Introduction
In 2004, interest in herbal mixtures with the names “K2” and “Spice” became apparent as
these blends began appearing in “headshops” and online. Although some of these mixtures come
in packages with warnings suggesting that they are not for human consumption (Figure 1), the
mixtures have been used as “herbal highs.”
The most common ingredient reported in these mixtures is 1-pentyl-3-(1-napthoyl)indole,
also known as JWH-018. While JWH-018 has cannabis-like effects similar to delta-9tetrahydrocannabinol (Δ9-THC) found in marijuana, they do not have similar structures (Figure
2). Both of these substances interact with the cannabinoid receptors, CB1 and CB2, with a higher
binding affinity reported for JWH-018 compared to Δ9-THC [1,2]. Less JWH-018 is, therefore,
needed in the body to have the same effects as a higher dose of Δ9-THC. Hallucination, distorted
perception, and tachycardia are common effects of usage for JWH-018 and Δ9-THC.
Previous studies of JWH-018 have included detection in incense packets using GC/MS
[3]. These studies have allowed these mixtures to be monitored before they become available on
the market. Determining appropriate methods for detecting metabolic products is beneficial for
law enforcement agencies. This is especially applicable since the Drug Enforcement Agency
(DEA) is conducting studies to determine if mixtures containing JWH-018 should be placed on
the controlled substances list prohibiting their sales [4].
The purpose of this study is to synthesize a JWH-018 metabolite where hydroxylation
occurs on the alkyl chain. This is the most common metabolite predicted in K2 users’ urine by
studies with rat liver microsomes reported by Wintermeyer et al [5]. The synthesized metabolite
will then be used as an analytical standard to quantitate the metabolite found in K2 users’ urine.
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The presence of this metabolite has only recently been confirmed with liquid
chromatography-mass spectrometry (LC-MS/MS) [6]. Developing a GC/MS method and
improving the method validation is needed for conclusive determination of a history of abuse.
Since previous studies in the group have shown that better detection limits are achieved
when the metabolite is derivatized with the same protecting groups used in the synthesis, the
synthetic target of this study was the silane derivative shown in Figure 3. The overall synthetic
scheme can be found in Figure 3 with the different reagents and conditions regarding each step.
In further studies, the removal of the protecting group and addition of the hydroxyl group will
take place. This will allow the hydroxyl group to be oxidized into a carboxylic acid which is the
second most common metabolite found in K2 users’ urine [6].

Figure 1. Different brands of ‘Spice’ herbal products illustrating differences in packaging and
herbal blend appearance. Some packages indicate not intended for human consumption.
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Figure 2. Structural formulas for Δ9-THC and JWH-018.

Experimental Procedures
Materials and Instrumentation. The solvents and reagents were purchased from EMD
Chemicals (Gibbstown, NJ), Sigma Aldrich (St. Louis, MO), and TCI America (Portland, OR).
The samples were analyzed using a Varian 450 gas chromatography system combined with a
Varian 320 MS. The GC had an injector temperature fixed at 300 °C, a split 10:1 ratio, and a
Zebron ZB-5HT Inferno 30M x 0.25 ID column. The temperature programming of the GC
varied for the steps. Steps 1 and 2 were held at 65 °C (2 min) then increased with a rate of 25
°C/min until 280 °C (2 min). For step 3, the temperature was held at 80°C then increased at a
rate of 25 °C/min to reach 310 °C (15 min). The MS conditions were as follows: scanning 50500 amu and 1 sec/scan.
Compound 1 (1-t-butyldimethylsilyl-5-bromopentane). 5-bromo-pentan-1-ol (3.6 mL,
29.7 mmole), imidazole (5.1 g, 74.9 mmole), and tert-butyldimethylsilyl chloride (TBDMSCL)
(5.9 g, 39.1 mmole) were dissolved in 10 mL DMF under N2 at 0 °C. The reaction stirred
overnight at room temperature. After the overnight reaction, the solution was diluted with 20
mL ethanol and quenched with 10 mL 1 M HCl. The clear, colorless solution was extracted
three times with petroleum ether (50 mL), dried with Na2SO4, and filtered. The petroleum ether
was removed by rotary evaporation and a clear oil (compound 1) was recovered and purified
using a silica column (petroleum ether/ethanol, 50:1 v/v) [7].
Compound 2 (1-(5-t-butyldimethylsilylpentyl)indole). Compound 1 (8.0 g, 28.5
mmol), KOH (0.5 g, 8.9 mmol), and 1.1 g indole (1.1 g, 9.4 mmol) were dissolved in 20 mL
DMF and the reaction was stirred overnight. The mixture was quenched after this time with 50
mL H2O. After the addition of H2O, the solution formed a white precipitate with an orange oil
on top of the solution. The solution was extracted three times with petroleum ether (50 mL),
washed three times with H2O (50 mL), dried with MgSO4, and filtered. Rotary evaporation was
used to remove the petroleum ether which was followed by purification by a silica column
(petroleum ether/diethyl ether, 9:1 v/v) [8].
Compound 3 (1-(5-t-butyldimethylsilylpentyl)-3-(napthoyl)indole).. Compound 2
(0.7 g, 2.2 mmol) was dissolved in CH2Cl2 (10 mL, 156.6 mmol) and cooled to 0 °C under N2.
To this solution, Me2AlCl (3.4 mL, 36.6 mmol) was added drop-wise and allowed to stir for 30
min. After this time, 1-naphthoyl chloride (0.4 mL, 2.6 mmol) was added in dry CH2Cl2 (10 mL,
156.6 mmol) to the pink solution and stirred for 2 hrs. After the solution changed to a bright
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orange color, DMF was removed by rotary evaporation to recover a brown oil. The oil was
purified with a silica column (petroleum ether/ethyl acetate, 9:1 v/v) to give a faint yellow oil
[9].

Figure 3. Reagents and conditions for the synthesis of JWH-018 hydroxylated metabolite; (a)
TBDMSCl, imidazole, DMF, 0°C to room temperature; (b) DMF, indole, KOH; and (c) 1naphthoyl chloride, CH2Cl2, Me2AlCl, 0°C.

Results and Discussion
During the synthesis of the JWH-018 metabolite, each compound was analyzed using
GC/MS to confirm product formation. The gas chromatogram, corresponding mass spectrum,
and fragmentation pattern were determined for each product.
The GC/MS data and fragmentation patterns for compound 1 are shown in Figures 4.
Compound 1 should have a molecular ion at m/z 281; however, this ion is not visible in the mass
spectrum (Figure 4B). In previous studies by this group, chemical ionization (CI) was used for
confirmation. In this instance, a molecular ion at m/z 281 was observed. The current GC/MS
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method uses electron ionization (EI) which did not fragment the compound in the same manner.
EI uses a hard ionization technique, whereas, CI is often referred to as a soft ionization
technique. EI may cause rearrangement of the chain to form a cyclic structure. A cyclic structure
will not produce a molecular ion at m/z 281.

Figure 4. (A) GC chromatogram of compound 1; and (B) corresponding MS spectrum.
It appears that compound 1 fragments in the MS to form an ion at m/z 166 as illustrated in
Figure 5. This ion occurs due to the breaking of the Si and O bond.

Figure 5. Fragmentation patterns of compound 1.
The product was also analyzed by 1H NMR. Peak assignments for compound 1 are
shown in Figure 6 and are labeled in the NMR spectrum (Figure 7) as follows: peaks 1 and 5 are
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triplets, peak 2 is a pentet, peaks 6 and 7 are singlets and peaks 3 and 4 is an unresolved
multiplet. These assignments correspond to those predicted thus confirming product formation.

Figure 6. Structure of compound 1 with NMR peak assignments

Figure 7. (A) H1 NMR of compound 1; (B) enlarged view of spectrum A centered around 1.23.4 ppm.
The GC/MS and fragmentation patterns of compound 2 are shown in Figure 8. The
molecular ion of compound 2 is found at m/z 317 and is visible in the mass spectrum (Figure
8B). Other abundant ions are found at m/z 130 and m/z 260. These ion formations indicate that
compound 2 was formed.
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Figure 8. (A) GC chromatogram of compound 2; and (B) corresponding MS spectrum.
The fragmentation patterns of compound 2 are shown in Figure 9. The ion at m/z 130 is
formed through loss of the butyl side chain and protecting group (-.(CH2)4OSi(CH3)2C(CH3)3).
The ion at m/z 260 is formed from loss of the tert butyl on the protecting group (-.C(CH3)3).

Figure 9. Fragmentation patterns of compound 2.
The GC/MS data and fragmentation patterns for compound 3 are visible in Figure 10.
Compound 3 has a molecular ion at m/z 471 visible in the mass spectrum (Figure 10B). The
other ions noted in the fragmentation patterns are at m/z 127 and 155.
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Figure 10. (A) GC chromatogram of compound 3; and (B) corresponding MS spectrum.
The ions at m/z 127 and 155 are from naphthalenyl and carbonylnaphthalenyl,
respectively. Another abundant ion is at m/z 414, which corresponds to loss of tert butyl from
the protecting group (-.C(CH3)3). This loss is identical to the loss found in compound 2 at m/z
260. The molecular ion and other ion formations indicate that the proper compound was formed
during synthesis.

Figure 11. Fragmentation patterns of compound 3.

Conclusion
In conclusion, the JWH-018 metabolite was formed with the protecting group attached in
place of the hydroxyl group (Figure 3 compound 3). This proved to have better detection limits
92

with GC/MS than the hydroxylated form of the metabolite. The appropriate GC/MS
methodology was determined during this project which will help in future studies regarding this
metabolite. Proper analytical standards are crucial to compare the standard retention time and
mass spectrum fragmentation patterns to metabolites found in the urine of K2 users.

Future Work
In future studies, the synthesis will be continued to form the hydroxylated metabolite
which can then be oxidized to form the carboxylic acid. Both metabolites will then be compared
to those found in K2 users’ urine. After the hydroxylated metabolite is formed, the detection
limits of the metabolite will be determined. In addition, future work will compare the methods of
GC/MS to the established one for LC-MS/MS. As a result of the gas chromatogram and mass
spectrum of compound 1 using EI, future studies will also analyze different brominated alkyl
chains to determine which chain lengths react to form cyclic structures.
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